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ABSTRACT 
 
In comparison to other Pseudomonas, P. aeruginosa grows poorly in L-lysine as a sole source of 
nutrient while fast growth mutants can be obtained. The proposed catabolic pathway involves 
lysine decarboxylation to cadaverine and its subsequent degradation through -glutamylation 
pathway to -aminovalerate and glutarate.  The lysine decarboxylase A (ldcA) gene, previously 
identified as a member of the ArgR regulon of L-arginine metabolism, was found essential for L-
lysine catabolism. The ldcA gene encodes a decarboxylase which takes L-lysine but not L-
arginine as substrate. Contrarily, the ldcA expression was inducible by L-arginine but not by L-
lysine. This peculiar arginine control on lysine utilization was also noted from uptake 
experiments. The lack of lysine-responsive control on lysine catabolism and its tight connection 
to arginine regulatory network provided an explanation of lysine as poor nutrient for P. 
aeruginosa. Catabolism of cadaverine, a product from lysine decarboxylation, was investigated 
and compared to that of putrescine, another diamine of similar biochemical properties that is 
derived from arginine and ornithine. While the -glutamylation pathway was first reported in E. 
coli for putrescine utilization, an expanded version of this pathway was found in P. aeruginosa 
with redundant enzymes for polyamine degradation. The PauR protein was identified as a 
transcriptional repressor of genes for the catabolism of putrescine and cadaverine, as well as their 
corresponding downstream metabolites, -aminobutyrate (GABA) and -aminovalerate (AMV). 
PauR shows distinct dimer configuration after glutaraldehyde crosslinkage, and possible 
conformational changes could be triggered by the presence of putrescine and cadaverine, but not 
GABA. A newly identified ABC transport system, encoded by the agtABCD operon, was found 
important for the uptake of GABA and AMV; and expression of which is controlled by the 
AgtSR two-component system. The CbrAB two-component system was proposed to regulate the 
catabolite repression control protein Crc through a small RNA CrcZ. A consensus CbrB 
recognition sequence was proposed based on the conserved palindromic nucleotide sequence in 
the upstream activating sequence of the crcZ promoter. Genetic studies indicated utilization of 
arginine, lysine and diamines (but not histidine, GABA and AMV) might be under CbrAB 
regulation through the CbrAB/CrcZ/Crc system in P. aeruginosa.  
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GENERAL INTRODUCTION 
 
Pseudomonas aeruginosa, an opportunistic human pathogen, is the leading source for 
pneumonia in immunosuppressed, cystic fibrosis, cancer and burn patients. This Gram-negative 
rod-shaped bacterium resides ubiquitously in a wide variety of environments. Exploration of 
catabolic pathways is of particular interest in such a nutritionally versatile organism. With the 
sequenced genome coupled with an impressive array of genetic and functional genomics tools, 
this organism is relatively amenable to investigation.  
 
P. aeruginosa cannot use L-lysine efficiently as sole source of nutrient for growth (19, 
85). However, mutants with improved growth on L-lysine can be isolated by repeated 
subcultures in L-lysine suggesting existence of catabolic genes on the chromosome (19). In this 
study, a peculiar arginine control on lysine utilization was unraveled in P. aeruginosa. The 
proposed pathway consists of lysine decarboxylation with formation of cadaverine and its 
subsequent degradation through the -glutamylation pathway (Figure 0.1). Catabolic enzymes, 
uptake and regulatory systems involved were analyzed in detail using genetic and biochemical 
approaches. 
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Figure 0.1. Lysine catabolic pathways.  
 
L-lysine decarboxylase pathway leading to cadaverine degradation into 5-aminovalerate 
and glutarate is shown in the center as the main route for L-lysine catabolism in P. 
aeruginosa. L-lysine transaminase and D-lysine dehydrogenase pathways are shown in 
the right. Broken arrows represent L-lysine monooxygenase pathway from P. putida 
which is not present in P. aeruginosa. Cadaverine degradation through the -
glutamylation pathway merges with the monooxygenase pathway of P. putida at 
aminovalerate which is further degraded into glutarate. 
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0.1   LYSINE CATABOLISM IN PSEUDOMONAS AERUGINOSA 
 
Possible pathways for L-lysine catabolism in bacteria. In microbes, lysine catabolism 
can be initiated either through monooxygenase, decarboxylase or transaminase activities (Figure 
0.1). While L-lysine is mainly degraded by 2-monooxygenase in P. putida, counterparts for this 
pathway are not present in P. aeruginosa (pseudomonas.com). On the other hand, pioneer 
biochemical studies using fast-growth mutants suggest lysine decarboxylation as the main 
catabolic route in P. aeruginosa (19, 81). Among the several amino acid decarboxylases, those 
that attack the basic amino acids, arginine, ornithine and lysine with subsequent polyamine 
formation, are the most significant physiologically (23, 29, 65). However, even the enzymology 
of this pathway has been established decades ago, lysine decarboxylation and regulatory 
mechanism involved were mostly unexplored at the genetic level in P. aeruginosa.  
 
Lysine deaminase activity can be detected in different species of the genus Pseudomonas. 
The AruH protein from P. aeruginosa has been studied and characterized as a transaminase able 
to remove the 2-amino group from arginine and other amino acids including lysine in vitro (103). 
In this study, the role of L-lysine transaminase pathway in P. aeruginosa metabolism will be 
investigated using genetics approach.  
 
D-lysine Catabolism. Our laboratory reported a novel racemase system formed by DauA 
and DauB to convert D-arginine into L-arginine through two step reactions with 2-keto-arginine 
as intermediate compound (52, 53). In these studies, DauA shows high deamination activity with 
 4 
D-lysine resulting in ketolysine and ammonia (53).  Growth on D-lysine as nitrogen source is 
also abolished in dauA mutant strain supporting the in vitro activity of DauA on D-lysine (53). 
 
On the other hand, the product from DauA dehydrogenase, 2-keto-lysine, is supposed to 
turn into the more stable cyclic form, 1-piperideine-2-carboxylate (36). Studies from P. putida 
suggest D-lysine catabolism with further degradation of this compound into L-pipecolate by the 
reductase DpkA (84). However, this pathway is still undefined in P. aeruginosa since no dpkA 
orthologue can be found on the chromosome and the corresponding enzymatic activity was not 
detectable (19).  
 
0.2   THE ARGININE EFFECT ON LYSINE UTILIZATION 
 
Inducible lysine utilization by arginine. P. aeruginosa has been considered unable to 
grow on L-lysine as sole carbon source and grows poorly on this compound as a nitrogen source. 
However, initial observations in this study indicate that in fact P. aeruginosa can grow on L-
lysine as sole carbon and nitrogen source; however, it needs to pass an extensively long lag 
phase of approximately 44 hrs before entering the exponential phase with an estimated 
generation time of 122 minutes. In addition, this long lag phase can be shortened significantly by 
supplementing the media with a small amount of arginine (~100 M). This phenomenon 
intrigued me to conduct a series of studies to understand how arginine triggers lysine utilization 
in this organism. 
 
 5 
 The ArgR regulon contains candidate transport and catabolic genes for lysine. The 
ArgR protein was initially identified as the major arginine-responsive transcriptional regulator of 
the AraC/XylS family. Using Affymetrix GeneChip® DNA microarray, a group of genes for 
basic amino acids uptake and catabolism emerge from the ArgR transcriptome analysis (60). 
Interestingly, orthologues of a subset of these genes have been reported as key transport systems 
and enzymes for lysine utilization in other bacteria. The transport systems PA5152-PA5155 and 
aotJQMP encoding two ABC transporters are the counterparts of PP0283-PP0280 and the 
PP4486-PP4482 in P. putida which have been reported to contribute in lysine utilization (82). 
These orthologues show high similarities in gene organization as well as in amino acids 
sequences (82-84).  
 
Because of its high induction level by arginine, PA1818 was initially proposed as a 
catabolic arginine decarboxylase under ArgR control. However, no enzyme activity is detectable 
using arginine as substrate in biochemical studies from our laboratory (29). Based on sequence 
analysis, PA1818 also possesses potentials to catalyze lysine decarboxylation. Up to date, there 
are two lysine decarboxylases identified from E. coli: the lysine decarboxylase C (LdcC) of low 
expression level with no response to exogenous lysine; and a well-studied inducible lysine 
decarboxylase CadA for acid stress responses (29, 39, 50). LdcC shows higher optimal pH and 
lower tolerance to heat than CadA (39, 50). Since PA1818 showed no response to acid stress 
(29), this result suggests PA1818 might be the counterpart of the non-inducible decarboxylase 
LdcC. And since P. aeruginosa has only one candidate for lysine decarboxylase, other amino 
acids decarboxylase systems such as glutamate or arginine decarboxylases might be responsible 
for acid stress responses in this organism. 
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In this study, ArgR is proposed to regulate lysine utilization which is inducible by 
arginine but not by lysine. This hypothesis may give an explanation to the long lag phase for 
growth in lysine as sole source of nutrient in P. aeruginosa. 
 
0.3   POLYAMINE CATABOLISM IN MICROORGANISMS 
 
L-lysine catabolism through the decarboxylase pathway leads to formation of cadaverine 
(Figure 0.1). On the other hand, ornithine decarboxylation yields putrescine, and L-arginine 
decarboxylation, with agmatine as intermediate product, which also leads to putrescine (13, 58). 
Many bacteria including Pseudomonas can use cadaverine and putrescine as sole source of 
nutrient for growth (12, 13, 93). As a continuation of my study on lysine catabolic pathway, 
cadaverine degradation was investigated and compared to putrescine in P. aeruginosa. 
 
Physiological significance of polyamines. Although their functions have not yet been 
fully understood, biogenic polyamines (diamines: diaminopropane, putrescine, cadaverine; and 
triamines: spermidine, norspermidine and spermine) are natural polycations involved in a wide 
range of biological reactions (8, 14, 102). In higher organisms, polyamines are involved in cell 
proliferation and differentiation (7). Decades of polyamine biology has been focusing in cell 
cycle control since impaired polyamine metabolism can be found in abnormal eukaryotic cells 
with high proliferation rates such as cancer cells (6, 62). In microbes, different sets of 
polyamines are present in each species which are controlled through uptake, biosynthesis and 
catabolism (49, 97). It is believed to bind nucleic acid-containing macromolecules through 
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charge interactions in vivo and are thought to play significant roles in the structural and 
functional organization of the chromosome and protect DNA from oxidative damage as free 
radical scavengers (26, 33, 38, 97). Exogenous polyamines also exert a significant effect on 
antibiotic susceptibility in bacteria (46-48). Other interesting studies link polyamines to 
microbial carcinogenesis, escape from phagolysosomes, biofilm formation, bacteriocin 
production, toxin activity and protection from oxidative and acid stress, showing the multifaceted 
roles of these intriguing molecules in nature (45, 90, 97). While intracellular polyamines play 
pivotal roles in ensuring optimal growth, accumulation of these compounds inside the cells may 
cause excess binding to DNA forming condensed complexes leading to protein synthesis 
inhibition and decrease in cell viability (11, 20, 55). Thus, balanced polyamine 
biosynthesis/catabolism and uptake/export appear to be required to adjust the optimal 
homeostasis of these compounds in accord with the growth environment. 
 
Cadaverine and putrescine metabolism in bacteria. Cadaverine and putrescine are 
diamines with a central methylene chain of similar length: 1,5-diaminopentane, and 1,4-
diaminobutane, respectively. It was first reported in E. coli that putrescine is degraded into γ-
aminobutyrate (GABA) through the -glutamylation pathway (42, 44). This pathway is initiated 
by γ-glutamylputrescine synthetase PuuA, followed by three reactions catalyzed by PuuB, PuuC, 
and PuuD.  
 
Recent studies from our laboratory found an expanded version of the -glutamylation 
pathway in P. aeruginosa for polyamine catabolism including cadaverine and putrescine. 
Different from E. coli, that the puu genes are clustered in a single locus of several transcriptional 
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units under negative control of PuuR (44, 70), puu orthologues are scattered on the chromosome 
of P. aeruginosa (www.pseudomonas.com). These genes are designated as polyamine utilization 
genes pauA, pauB, pauC and pauD (Figure 0.1). Interestingly, there are seven γ-
glutamylpolyamine synthetases (PauA1-7) for the first step of the pathway (105). Many of these 
enzymes are able to catalyze the glutamylation of different polyamines. Following the 
glutamylation, the free amino group is subjected to deamination either by oxidation or 
transamination. Four PauB candidates for oxidative deamination can be found in P. aeruginosa 
which are supposed to function only under aerobic conditions. On the other hand, SpuC was 
proposed to catalyze transamination between glutamylpolyamine and alanine regardless of the 
oxygen level (105). Following deamination, the aldehyde compounds were suggested to be 
degraded into carboxylates by the dehydrogenase PauC (KauB) (13), This enzyme was initially 
identified as a NAD(P)-dependent dehydrogenase for ketoarginine utilization (104). Since pauC 
mutant cannot grow on putrescine, this is the only step without redundant enzymes. And finally, 
the glutamyl group is released by PauD in the last step of the pathway. Two -glutamyl 
hydrolases were proposed for P. aeruginosa: PauD1 (SpuA) which affects spermidine utilization 
but not to putrescine (59); and PauD2 (PA1742) which requires further studies to confirm its 
involvement in the pathway. 
 
Regulation on -glutamylation pathway.  Based on studies in E. coli, putrescine -
glutamylation and deglutamylation are negatively regulated by PuuR (Gene ID 945886) in the 
first and last steps of the Puu pathway (44). By BLAST search, there is only one candidate for 
PuuR orthologue in P. aeruginosa, PA5301, showing 45% identities and 64% similarities to E. 
coli PuuR. In the second part of this study, this regulatory protein was shown involved not only 
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in the -glutamylation pathway but also in catabolism of their corresponding downstream 
metabolites, -aminobutyrate (GABA) and -aminovalerate (AMV).  
 
GABA/AMV catabolism in P. aeruginosa. Like putrescine and cadaverine, it is possible 
that the downstream GABA and AMV share similar pathways with common enzymes for the 
degradation (12, 42). The gabDT operon encodes for a dehydrogenase GabD and a transaminase 
GabT which along with the transaminase GabT2 (PA5313) contribute to GABA degradation into 
succinate (13). Besides, it has been reported in P. putida that davDT are the essential genes for 
AMV catabolism (82); the DavD and DavT exhibit 92% and 82% sequence similarity to P. 
aeruginosa GabD and GabT, respectively. In this study, the roles of gabDT and gabT2 were 
investigated for AMV degradation into glutarate.  
 
This study will provide valuable information on the intriguing connection between lysine 
catabolism to arginine through arginine-responsive regulatory gene ArgR in P. aeruginosa. This 
catabolic pathway became even more complex by redundant enzymes for cadaverine and 
putrescine degradation through the -glutamylation pathway. This will be a first complete report 
on enzymatic, genetic and regulatory aspects of lysine-cadaverine-aminovalerate degradation in 
this organism. 
 
0.4   CARBON CATABOLITE REPRESSION IN PSEUDOMONAS AERUGINOSA 
 
Pseudomonas aeruginosa is noted for its ability to use a wide range of carbon and 
nitrogen sources. Different from E. coli and B. subtilis where glucose is the preferential carbon 
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source, P. aeruginosa prefers carboxylates of the tricarboxylic acid (TCA) cycle such as 
succinate which can exert carbon catabolite repression (CCR) over sugars (including glucose), 
amino acids and other nutrients (15, 57, 92). Hallmarks of catabolic regulatory mechanisms like 
inducer exclusion and cAMP-dependent transcriptional activation play minor role in CCR 
control of this organism. Instead, complex regulatory networks with different regulatory 
mechanisms are used to optimize metabolism to achieve efficient growth and cellular carbon-
nitrogen balance in P. aeruginosa. 
 
While the CbrAB two-component system is essential for growth on several carbon and 
nitrogen sources for Pseudomonas (54, 74), the crc (catabolite repression control) gene encoding 
a RNA-binding protein has been reported to participate in control of several catabolic operons of 
less-preferred nutrients (94). It had been a puzzle to understand how CbrAB and Crc work 
together to regulate different catabolic pathways until recent discovery of the small RNA CrcZ 
(94). On the other hand, CbrA and CbrB exhibit moderate sequence similarity to the well-studied 
NtrB and NtrC two-component system for nitrogen assimilation controls in Gram-negative 
bacteria (31, 74). Combined regulation of CbrAB with NtrBC has been reported for arginine and 
histidine utilization in pseudomonas (54, 107). The last chapter of this study demonstrates how 
CbrAB regulates crcZ to release CCR by the Crc protein. Possible cross talk between CbrAB and 
NtrBC two-component systems was also investigated. 
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CHAPTER ONE 
 
 
L-LYSINE CATABOLISM IS CONTROLLED BY L-ARGININE AND ARGR IN 
PSEUDOMONAS AERUGINOSA PAO1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This work was partially published by Han-Ting Chou, Mohamed Hegazy and Chung-Dar Lu in 
“L-lysine Catabolism is Controlled by Arginine/ArgR in Pseudomonas aeruginosa PAO1”.  
J. Bacteriol. 2010 Nov; 192(22):5874-80. 
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1.1   INTRODUCTION 
 
Decarboxylation of amino acids, including lysine, arginine, and glutamate, is important for 
bacterial survival under low pH (9, 23, 65). Lysine is abundant in rhizosphere where fluorescent 
Pseudomonas preferentially reside, and serves as nitrogen and carbon source by these organisms 
(85). In microbes, lysine catabolism can be initiated either through monooxygenase, 
decarboxylase or transaminase activities. The monooxygenase pathway has been considered as 
the major route for L-lysine utilization in Pseudomonas putida, and davBATD encoding enzymes 
for the first four steps of the pathway have been characterized (82, 83). In contrast, P. aeruginosa 
cannot use exogenous L-lysine efficiently for growth (19, 81). It has been reported that 
enzymatic activities for the first two steps of the monooxygenase pathway are not detectable in P. 
aeruginosa, and no davBA orthologs can be identified from this organism (81, 82). 
 
Mutants of P. aeruginosa with improved growth on L-lysine and a high level of lysine 
decarboxylase activity can be isolated by repeated subcultures in L-lysine (19). This suggests 
that in P. aeruginosa, L-lysine utilization might be mediated by lysine decarboxylase pathway 
with cadaverine and 5-aminovalerate as intermediates. Alternatively, conversion of L-lysine into 
5-aminovalerate may also be accomplished by a coupled reaction catalyzed by AruH and AruI. 
The AruH and AruI enzymes were reported as arginine:pyruvate transaminase and 2-ketoarginine 
decarboxylase, respectively (104). Interestingly, transamination by AruH using L-lysine as amino 
group donor can also be detected in vitro (103). The reaction product -keto--aminohexanoate 
can potentially be decarboxylated into 5-aminovalerate by AruI providing an alternative route for 
lysine degradation.  
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In this study, the lysine decarboxylase pathway was shown to be the main route for lysine 
utilization under arginine control. Expression of the ldcAB operon encoding L-lysine 
decarboxylase and a putative lysine/cadaverine antiporter was analyzed regarding its response to 
L-lysine, L-arginine, and the arginine-responsive regulator ArgR. Enzyme characterization was 
performed to verify the function of LdcA as L-lysine decarboxylase. Arginine control on lysine 
incorporation was also investigated by genetic studies and uptake experiments. The peculiar role 
of ArgR controlling arginine and lysine uptake and catabolism provides the explanation for poor 
growth in lysine, and it implies a higher level of complexity in metabolic networks of 
pseudomonads. 
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Table 1.1. Strains and Plasmids 
Strain or plasmid Genotype or description
a
  Source 
E.coli strains   
DH5 F
-Φ80dlac ∆M15 ∆(lacZYA-argF)U169 deoR recA1 
endA1 hsdR17 (rK
-
 mK
-
) supE44 λ- thi-1gyrA96 relA 
Bethesda 
Research 
Laboratories 
TOP10 F- mcrA (mrr-hsdRMS-mcrBC) 80lacZM15 
DlacX74 recA1 araD139 (ara-leu)7697 galU galK 
rpsL (Str
R
) endA1 nupG 
Invitrogen 
SM10 thi-1 thr leu tonA lacY supE recA::RP4-2-Tc::Mu 
(Km
r
) 
(91) 
P. aeruginosa strains   
PAO1 Wild type (27) 
PAO1-Sm
r
 Spontaneous Sm
r
 mutant strain of PAO1 (35) 
PAO501 argR::Gm
r
 (76) 
PAO1214 aotJ::Tn5-751 insertion mutant of PAO1 (76) 
PAO5715 aruC~aruE::Gmr This study 
PAO5716 ldcA::Tc
r
 This study 
PAO5717 ldcB::Tc
r
 This study 
PAO5602 aruH::Tc
r
 ∆aruF (104) 
PAO5718 aruC~aruE::Gmr, ldcA::Tcr This study 
PAO5720 aruH::Tc
r
 This study 
PAO5721 aruI::Tc
r
 This study 
PAO5802 dauA::Tc
r
 (27, 53) 
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Plasmids   
pRTP1 Amp
r 
Sm
s 
conjugation vector (95) 
pRTP2 pRTP1 derivative EcoRI site deleted  (52) 
pGM1 Bla gen; gentamicin resistance gene cassette with 
omega loop on both ends 
(88) 
pUCP18 Escherichia-Pseudomonas shuttle vector.  (89) 
pHC5306 pUCP18 derivative carrying ldcA gene This study 
pHC5307 pUCP18 derivative carrying aruH gene This study 
pBAD-His6 Modified protein expression vector derived from 
pBAD-HisA 
(52) 
pBAD-ldcA 6 x His-tagged LdcA protein expression vector This study 
pQF50 bla lacZ transcriptional fusion vector (18) 
pQF52 bla lacZ translational fusion vector derived from 
pQF50 
(76) 
pST500 aotJ::lacZ translational fusion of pQF52 (75) 
pZY5 PA4980::lacZ translational fusion of pQF52 (104) 
pHT1818 ldcA::lacZ transcriptional fusion of pQF50 This study 
a
 Cam
r
, chloramphenical resistance; Km
r
, kanamycin resistance; Sm
r
, streptomycin resistance; 
Sm
s
, streptomycin sensitive; Tc
r
, tetracycline resistance; Gm
r
, gentamicin resistance; Amp
r
, 
ampicillin resistance. 
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 1.2   MATERIALS AND METHODS 
 
Bacterial strains, plasmids, media, and growth conditions. Bacterial strains and plasmids 
used in this study are listed in Table 1.1. E. coli and P. aeruginosa strains were grown in Luria-
Bertani (LB) medium supplemented with or without antibiotics at conventional concentrations 
(104). Minimal medium P containing the indicated carbon sources at 20 mM and nitrogen 
sources at 5 mM was used for the growth of P. aeruginosa (27).  
 
Construction of ldcA::lacZ fusion. The upstream regulatory region of the ldcAB operon 
covering 635-bp upstream from of the start codon and the first 24-bp of the structural gene was 
PCR amplified from the genomic DNA of P. aeruginosa PAO1 using the following primers: 5‟-
TCA CTC TGG GCG CAA GCT TAG GCG CCG GTC GGC-3‟ and 5‟-GGG AAA TTT GAG 
GTC TTT-3‟.  PCR product was cloned into pQF50 and confirmed by DNA sequencing. 
 
Construction of mutant strains. For tetracycline resistant mutants, DNA fragments 
covering the genes of interest were PCR amplified from PAO1 genomic DNA using the 
following primers: for ldcAB mutants, 5‟-ATG TAT AAA GAC CTC AAA TTT CCC GTC CTC-
3‟ and 5‟-TCA GTC ATT GGC TTT GAG CGT CGG CAC TCC-3‟; for aruHI mutants, 5‟-GTC 
TAA GCT TGA CTG GCC TGG CGC GCG TCG-3‟ and 5‟-CGC AAG CTT CGG GCA GTC 
CGG CGT GAC CCT-3‟. PCR products were cloned into a conjugation vector pRTP1 (95) and 
the tetracycline resistance cassette was introduced by using EZ-Tn5 <TET-1> insertion system 
(Epicentre). For gentamicin deletion mutants, two flanking regions of a targeted gene were 
amplified by PCR with following primers: 5‟- GAG GGA TCA CTC GGG TGC ATA CTT CTT 
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CTA CG -3‟, 5‟-GAG GAA TTC AGC GCT TCC AGG TCG TTG TAG -3‟, 5‟-GAG GAA TTC 
GAG CGC TAC GTC GAA CAG GAC ATG A -3‟ and 5‟- GAG AAG CTT CAA TCC GAG 
CAG GTT GCT CAT GGT C -3‟. The PCR products were cloned into pRTP1. A cassette 
carrying gentamicin-resistance gene from pGM1 was inserted into the conjunction of the two 
DNA fragments (88). For gene replacement, E. coli SM10 was served as the donors in biparental 
mating with PAO1-Sm
r
 (21). The desired knockout mutants were selected on LB plates 
containing streptomycin and either gentamicin or tetracycline, and the mutation was confirmed 
by PCR.  
 
Constitutive expression from pUCP18. Full length ldcA (PA1818) and aruIH 
(PA4976~PA4977) genes were successfully PCR amplified and subcloned into pUCP18 to 
construct pHC5306 and pHC5307 using the following primers: PA1818F 5‟-TGA AGA TCT 
GAG GAG TCA ACA ATG TAT AAA GAC CTC-3‟, PA1818R 5‟-CCC AAG CTT TCA TTC 
CTT TAT GCA TTC AAC GGT-3‟, PA4976F 5‟-CAC GGA TCC GCT TGT GGG AAT GGG 
AGC AAG AGC-3‟ and PA4976R 5‟-CAC AAG CTT CAT CGT GGT TTC CGA ATC GTG 
GTG AC-3‟. These plasmids can reach 10 to 25 copy numbers per cell with constitutive 
expression in P. aeruginosa (89).  
 
Measurements of β-galactosidase activity.  The cells were grown in the minimal medium P 
containing the carbon and
 
nitrogen sources as indicated. Cells in the mid-log phase were 
harvested by centrifugation, and then passed through a French press cell at 8500 lb/in
2
 The cell 
debris were removed by centrifugation at 20,000 g for 15 min, at 4 C, and protein 
concentrations in the crude extracts were determined by the Bradford method (5). The levels of 
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β-galactosidase activity were measured using Miller‟s method (64).  
 
Overexpression and purification of LdcA. Full-length ldcA was amplified from the 
genomic DNA of P. aeruginosa using designed primers: 1818F 5‟-TAT AAA GAC CTC AAA 
TTT CCC GTC-3‟ and 1818R 5‟-TCA TTC CTT TAT GCA TTC AAC GGT -3‟. The PCR 
product was sub-cloned into pBAD-HisD, a modified pBAD expression vector (52, 103). 
Recombinant 6xHis-LdcA was expressed in Escherichia coli TOP10 (Invitrogen life 
technologies) by arabinose induction. Cell extract was obtained by passing through a French 
pressure cell at 8,500 lb/in
2 
followed by centrifugation at 25,000 g for 30 minutes at 4 C. 
Soluble His-LdcA protein was purified from HisTrap HP column (GE Healthcare) at the 
concentration of 100 mM imidazole. Eluted fractions detected by UV were analyzed by SDS 
PAGE, pooled together and concentrated by Amicon Ultra-15 centrifugal filter unit (Millipore). 
Active fractions were determined by lysine decarboxylase assay as described below. Protein 
concentration was determined
 
by the method of Bradford (5). 
 
Measurements of lysine decarboxylase activity.  Purified His-LdcA was used to test L-
lysine decarboxylation in vitro. Enzyme-catalyzed decarboxylation was assayed by measuring 
the liberated 
14
CO2 at 37 ºC as previously described with slight modification (101). The assay 
was carried out in a standard scintillation vial and the liberated 
14
CO2 was trapped by a filter 
paper pre-impregnated with 0.1 ml barium hydroxide in the cap. One milliliter of standard 
reaction mixture contains 125 M pyridoxal 5‟-phosphate, 100 g/ml acetylated bovine serum 
albumin, 0.2 Ci [14C]-L-lysine and 3 mM of cold L-lysine in 100 mM Tris buffer at pH 8.5. The 
mixture was incubated at 37 ºC in water bath and the reaction was started by adding 1.5 g of 
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purified LdcA. Reaction was stopped by adding seven drops of 1N H2SO4, and continued the 
incubation for 30 min more for complete absorption of CO2. Labeled CO2 was measured in a 
liquid scintillation counter. Apparent kinetics parameters were determined using non-linear 
regression equations of the kinetics module of SigmaPlot 9.0 software. 
 
L-lysine uptake experiments. Radiolabeled L-lysine was used for uptake assays as 
previously described with slight modification (59). Cultures were grown in glutamate-MMP in 
the absence or presence of 20 mM L-arginine or L-lysine. Cells were harvested during 
logarithmic growth (OD600 = 0.5~0.8), washed twice and resuspended at a concentration of ca. 
10
8
 cells/ml (OD600 = 0.1) using MMP containing chloramphenicol (250 μg/ml). After incubation 
of the cell suspension for 5 min in 37°C water bath, 
14
C-labeled L-lysine was added to a final 
concentration of 20 μM (10 mCi/mmole), and samples (0.5 ml) were withdrawn at various time 
intervals. Cells were collected on a cellulose membrane filter (0.22 μm pore size, type GS, 
Millipore) and washed with 10 ml of MMP. Membranes were air dried in clean scintillation vials 
overnight. Incorporated radioactivity was measured using adequate scintillation liquid and 
spectrometer (Beckman).  
 
DNA microarray. GeneChip® P. aeruginosa Genome Array from Affymetrix was used for 
transcriptome analysis of physiological responses to different nutrients in P. aeruginosa.  All 
cells were grown aerobically in minimal medium P with 350 rpm shaking at 37 C supplemented 
with 20 mM L-glutamate as background nutrient until optical density at 600nm reaches 0.55 ± 
0.05. Cells were harvested by centrifugation for 5 minutes at 4 C. Total RNA samples were 
isolated by RNeasy purification kit following instructions of the manufacturer (Qiagen). Reverse 
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transcription for cDNA synthesis, fragmentation by DNase I treatment, cDNA probe labeling and 
hybridization were performed according to the instructions of GeneChip® manufacturer 
(Affymetrix). Data were processed by Microarray Suite 5.0 software normalizing absolute 
expression signal values to a target intensity of 500. GeneSpring GX software (Silicon Genetics) 
was used for expression pattern analysis and comparison. Genes showing consistent expression 
profiles in duplicates were selected for further analysis. All data were deposited in the Gene 
Expression Omnibus (GEO) database (GSE9926). 
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  1.3   RESULTS 
 
ArgR dependent induction of the ldcA promoter by arginine but not by lysine. The 
putative ldcAB operon was initially identified as a member of the ArgR regulon from 
transcriptome analysis (60). ArgR is autoinducible from the aot-argR operon and is initially 
identified as the major regulator of aerobic arginine catabolism and biosynthesis in response to 
arginine (76). The ldcA promoter in response to exogenous L-arginine and L-lysine was tested by 
measurements of β-galactosidase activities in PAO1 harboring pHT1818, a PldcA::lacZ fusion. As 
shown in Table 1.2, exogenous arginine but not lysine exerted strong induction effect (12 folds) 
on the ldcA promoter.  
 
The ldcA gene was shown essential for lysine utilization. The results of ldcA expression 
in response to arginine from above experiments led me to propose ldcA encodes an arginine-
inducible arginine decarboxylase (ADC), the first enzyme of the ADC pathway (69). Arginine 
succinyltransferase (AST) and arginine transaminase (ATA) pathways were reported to sustain 
for aerobic growth in P. aeruginosa (104). In order to test for ADC pathway as an alternative 
route for arginine utilization, I used a double mutant strain PAO5602 devoid of the AST (by aruF 
deletion) and ATA (by aruH::Tc
r
) pathways while the putative ADC pathway remained intact 
(Table 1.3). However, growth on L-arginine as sole source of carbon and nitrogen was 
completely abolished in PAO5602 and growth on L-arginine can be restored when the mutant 
strain was complemented by pHC5307, which expressed aruH from the lac promoter on the 
pUCP18 vector (Table 1.4). Contrarily, PAO5602 harboring pHC5306 (ldcA in pUCP18) still  
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Table 1.2. Promoter activities of aotJ, and ldcA in response to arginine and lysine 
 
 
 
Strain Genotype Nutrients 
Sp act (mole/mg/min)a for: 
PldcA::lacZ PaotJ::lacZ 
PAO1 Wild type G   0.8  (1)   14  (1) 
A+G   9.5  (12)   61  (4) 
L+G   1.2  (1.5)   18  (1.2) 
PAO5715 aruC~aruE::Gmr G   4.1  (1)   58  (1) 
A+G  16.0  (4)  105  (2) 
L+G   4.0  (1)   26  (0.5) 
 
 
 
a
 Cells were grown in minimal medium P supplemented with 20 mM of : L, lysine, A, arginine or 
G, glutamate. Specific activities represent the averages from three measurements with standard 
errors below 5%. Fold changes are in parenthesis. 
 
 
  
 23 
 
 
 
 
Table 1.3. Lysine decarboxylase pathway is the main route for lysine catabolism 
 
 
 
 
Strain Genotype 
Affected 
Pathway 
Supplements
a
 
Lc Ln Ac An GN 
PAO1 WT none + ++ +++ +++ +++ 
PAO5716 ldcA::Tc
r
 LDC − − +++ +++ +++ 
PAO5717 ldcB::Tc
r
 LDC +/− ++ +++ +++ +++ 
PAO5720 aruH::Tc
r
 ATA + ++ +++ +++ +++ 
PAO 501   argR::Gm
r
 AST/LDC − + + ++ +++ 
PAO5602 aruH::Tc
r
/aruF AST/ATA ++ +++ − − +++ 
PAO5715 aruC~aruE::Gmr AST ++ +++ + ++ +++ 
PAO5718 aruC~aruE::Gm
r
 
ldcA::Tc
r
 
LDC/AST M M + ++ +++ 
 
 
 
a
 Logarithmically growing cells were plated on MMP solid agar media supplemented with: Lc, 
20 mM lysine + 5 mM ammonia; Ln, 5 mM lysine + 20 mM glucose; Ac, 20 mM arginine + 5 
mM ammonia; An, 5 mM arginine + 20 mM glucose; GN, 20 mM glucose + 5 mM ammonia; 
Growth at 37°C were recorded daily during 3 days of incubation period: +++, growth in one day; 
++, growth in 2 days; +, growth in 3 days; +/−, faint growth in 3 days; −: no growth in 3 days; M: 
growth under stress with high mutation rate. 
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showed no growth on L-arginine. From these results I concluded that ldcA is not involved in 
arginine utilization in P. aeruginosa PAO1. 
 
Surprisingly, the ldcA mutant strain, PAO5716, lost the ability to grow on lysine while 
arginine utilization remained unaffected (Table 1.3). Introducing pHC5306 to PAO5716 
complemented the growth defect on lysine. Even growth of the wild type strain PAO1 on lysine 
can be enhanced by the presence of pHC5306. These data support that ldcA may encode a lysine 
decarboxylase that is essential for L-lysine catabolism via the decarboxylase pathway (19).  
 
LdcA as lysine-specific PLP-dependent decarboxylase. To further confirm the enzymatic 
function of LdcA in lysine degradation, initial characterization of a purified His-tagged LdcA 
was performed with radioactive-labeled L-lysine to determine the reaction rate by measuring the 
liberated 
14
CO2. As shown in Figure 1.1A, LdcA possesses calculated Km and Vmax values of 
0.73mM and 2.2 mole/mg/min, respectively. An estimated Hill slope of 2.0 indicated 
cooperative substrate activation by L-lysine. The decarboxylase activity of LdcA was also 
checked with 
14
C-labeled L-arginine as substrate, and no activity on L-arginine can be detected. 
 
A pyridoxal 5‟-phosphate (PLP) binding site of LdcA was predicted in 
A387THSTHKMLAAF398, which shows 90% and 91 % similarities to the PLP binding sites of E. 
coli lysine decarboxylase (CadA ; ETESTHKLLAAF) and arginine decarboxylase (AdiA; 
ATHSTHKLLNAF), respectively (68). Indeed, when PLP was removed from the reaction 
mixture, enzyme activity was abolished for LdcA (data not shown).  
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Figure 1.1. Lysine decarboxylase enzyme characterization.  
 
His-tagged LdcA protein was purified from E. coli. Enzyme-catalyzed lysine 
decarboxylation was assayed by measuring the liberated 
14
CO2 as previously described in 
methods. A, Kinetics studies exhibiting cooperative substrate activation pattern with the 
corresponding Hill slope plot. Assays with increasing lysine concentrations were 
performed at pH 8.5, 37°C. B and C, Optimal conditions for lysine decarboxylation were 
tested as described in methods. D, Cold polyamines or amino acids (5 mM) were added 
into the standard reaction mixture to test for allosteric effects. 
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The optimal pH and temperature for LdcA were also determined. As shown in Figure 1.1C 
and 1.1D, LdcA exhibited a maximum activity around 37ºC, pH 8.5 with L-lysine as substrate. 
At pH 6, almost no activity was detectable for LdcA in this acidic environment (data not shown). 
These results strongly suggest that LdcA may not be involved in acid stress as E. coli CadA and 
AdiA do (9, 63, 100) but rather is suitable for lysine catabolism under alkaline conditions. 
 
The potential effects of L-arginine and compounds derived from L-arginine/ornithine/lysine 
decarboxylation (agmatine, putrescine, and cadaverine) on LdcA were tested. An inhibition effect 
was detected by the last three compounds but not by L-arginine (Figure 1.1B). These results 
imply that arginine intervention on lysine utilization is exerted only at the transcriptional level, 
and that lysine decarboxylation is subjected to product inhibition by cadaverine and other 
polyamines. 
 
Lysine uptake was enhanced by exogenous arginine but not lysine. Arginine effect on 
lysine utilization may range from uptake to degradation. In order to investigate this hypothesis, 
lysine uptake was examined in a pair of isogenic strains of P. aeruginosa, PAO1 (wild type) and 
PAO501 (argR::Gm-R). Cells were grown in minimal medium P with L-glutamate as the 
background nutrient with or without addition of exogenous L-arginine or L-lysine. The uptake of 
lysine in cell suspensions was examined. As shown in Figure 1.2, uptake of lysine was 
significantly induced by the presence of exogenous arginine but not by lysine. Interestingly, this 
arginine inducible lysine uptake was also ArgR dependent. 
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A. 
 
 
 
 
 
 
 
B. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2. Enhanced lysine uptake by arginine.  
 
Induction of L-lysine uptake by exogenous arginine in A, P. aeruginosa PAO1 and B, its argR 
mutant. Cultures grown in glutamate-MMP in the absence (diamond) or in the presence of L-
arginine (square) or L-lysine (triangle) were harvested during exponential growth and used for L-
lysine transport assays as described in Materials and Methods. 
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Improved growth on lysine by exogenous arginine in PAO1. All my data indicated that 
expression of ldcA, the essential gene for lysine catabolism, is controlled by ArgR in response to 
L-arginine but not to L-lysine. In the wild type strain PAO1, the estimated generation time was 
about 122 minutes when grown on L-lysine; however, it experienced a long lag phase of 44±2 h. 
I reasoned this growth curve as lack of ldcA induction by exogenous lysine, and hypothesized 
that growth of PAO1 on lysine can be improved by a trace amount of L-arginine to kick off ldcA 
expression. Indeed, addition of 0.15 mM L-arginine removed completely the otherwise long lag 
phase while the generation time remained unchanged (data not shown).  
 
The basal level of ldcA expression is elevated in the mutant devoid of the major 
arginine catabolic pathway. In analysis of the growth phenotype of PAO5602 (an arginine no-
grower), I observed significant improvement of this strain on lysine in comparison to PAO1 
(Table 1.3). Similar growth behavior on lysine was also detected in PAO5717, an aruC-E 
deletion mutant devoid of the major pathway (AST) for arginine catabolism (35). One hypothesis 
was that the intracellular level of arginine may be elevated when the major catabolic pathway is 
blocked, which in turn activates ArgR to induce the ArgR regulon (60) including the aotJQMOP-
argR operon for uptake and regulation, ldcAB, and many others. To test this hypothesis, I 
compared the activities of aotJ and ldcA promoters from lacZ fusions in PAO1 and PAO5717. As 
shown in Table 1.2, the basal level of these two promoters was increased 4-5 fold in PAO5717, 
and they were still responsive to the presence of arginine but not lysine in both strains. These 
results support the hypothesis of an activated ArgR regulon and hence high lysine uptake and 
catabolism in AST mutant strains.  
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Potential lysine catabolism by transamination. While the LdcA-catalyzed 
decarboxylation appeared to be the major route for lysine catabolism, L-lysine can potentially be 
degraded by other approaches, e.g. transamination. One possible candidate was AruH, which has 
been studied and characterized in vitro as a transaminase able to remove the α-amino group from 
arginine and lysine (103). Although the ldcA mutant lost completely the capability to grow on L-
lysine as sole source of carbon and/or nitrogen (Table 1.3), introducing aruH carried on 
pHC5306 to this mutant indeed restored growth on lysine as sole source of nitrogen but not 
carbon (Table 1.4).  
 
Transcriptome analysis reveals lysine-inducible genes. DNA microarray experiments 
were performed to understand genome-wide responses of P. aeruginosa PAO1 to exogenous L-
lysine and L-arginine at exponential growth phase. The results showed no response to exogenous 
lysine of the uptake and catabolic genes for lysine utilization identified in this chapter (Tables 
1.5). This reinforces the model of lysine utilization under arginine control.  
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Table 1.4. Effects of constitutive expression of ldcA or aruH 
 
 
 
 
Strain 
Affected 
Pathway 
Plasmid Genotype  
Supplements
a
 
Lc Ln Arg Agm 
PAO1 none pUCP18 WT, pUCP18 + ++ +++ +++ 
  pHC5307 WT, pUCP18/aruH + +++ +++ +++ 
  pHC5306 WT, pUCP18/ldcA +++ +++ +++ +++ 
PAO5716 LDC pUCP18 ldcA::Tc
r
, pUCP18 − − +++ +++ 
  pHC5307 ldcA::Tc
r
, 
pUCP18/aruH 
− +++ +++ +++ 
  pHC5306 ldcA::Tc
r
, 
pUCP18/ldcA 
+++ +++ +++ +++ 
PAO5602 ATA/AST pUCP18 aruH::Tc
r
/aruF, 
pUCP18 
+++ +++ − +++ 
  pHC5307 aruH::Tc
r
/aruF, 
pUCP18/aruH 
+++ +++ +++ +++ 
  pHC5306 aruH::Tc
r
/aruF, 
pUCP18/ldcA 
+++ +++ − +++ 
 
 
a
 Logarithmically growing cells were subjected to growth phenotype test in MMP media 
supplemented with: Lc, 20 mM lysine + 5 mM ammonia; Ln, 5mM lysine + 20 mM glucose; Arg, 
20 mM arginine; Agm, 20 mM agmatine; and GN, 20mM glucose + 5 mM ammonia. Aerobic 
growth at 37°C was monitored during 3 days: +++, prominent growth in 1 day; ++, growth in 2 
days; +, growth in 3 days; −, no growth in 3 days. 
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Table 1.5. L-arginine inducible genes for lysine utilization selected from DNA microarray analysis 
 
    Signal Value
b
   
PA ID
a
 Gene  Glu Glu Glu Glu Glu Glu      Annotations 
    Glu Arg Put GABA Lys Cad AMV   
          PA0888 aotJ 1911 7331 (4) 1567 (1) 1228 (1) 1067 (1) 1369 (1) 1262 (1) arginine/ornithine binding protein  
PA0889 aotQ 432 2157 (5) 318 (1) 399 (1) 453 (1) 470 (1) 303 (1) arginine/ornithine transport protein  
PA0890 aotM 700 2962 (4) 516 (1) 781 (1) 806 (1) 807 (1) 822 (1) arginine/ornithine transport protein  
PA0892 aotP 1461 4401 (3) 1051 (1) 1500 (1) 1959 (1) 2167 (1) 2039 (1) arginine/ornithine transport protein  
PA0893 argR 671 2090 (3) 526 (1) 606 (1) 1050 (2) 1114 (2) 1135 (2) transcriptional regulator  
          PA5152 
 
1918 4617 (2) 1377 (1) 935 (0) 1786 (1) 1210 (1) 1185 (1) ATP-binding component of ABC transporter  
PA5153 
 
4771 14117 (3) 2954 (1) 1298 (0) 4147 (1) 2141 (0) 2160 (0) periplasmic binding protein  
PA5154 
 
912 2371 (3) 383 (0) 271 (0) 1410 (2) 750 (1) 694 (1) permease of ABC transporter 
PA5155 
 
607 2105 (3) 327 (1) 194 (0) 372 (1) 319 (1) 270 (0) permease of ABC transporter 
          PA1818 ldcA 581 3070 (5) 531 (1) 379 (1) 997 (2) 712 (1) 603 (1) lysine decarboxylase  
PA1819 ldcB 190 796 (4) 152 (1) 134 (1) 445 (2) 579 (3) 500 (3) probable lysine/cadaverine antiporter  
          PA4975 
 
83 225 (3) 70 (1) 71 (1) 345 (4) 55 (1) 93 (1) NAD(P)H quinone oxidoreductase  
PA4976 aruH 98 192 (2) 80 (1) 83 (1) 630 (6) 133 (1) 53 (1) Arginine:Pyruvate Transaminas  
PA4977 aruI 68 149 (2) 80 (1) 130 (2) 424 (6) 119 (2) 121 (2) 2-ketoarginine decarboxylase  
PA4978 
 
108 177 (2) 81 (1) 80 (1) 940 (9) 292 (3) 171 (2) hypothetical acetyl-CoA C-acetyltransferase  
PA4979 
 
83 17 (0) 44 (1) 27 (0) 887 (11) 168 (2) 69 (1) probable acyl-CoA dehydrogenase  
PA4980 
 
122 687 (6) 232 (2) 149 (1) 2241 (18) 66 (1) 95 (1) putative enoyl-CoA hydratase/isomerase  
PA4981   54 573 (11) 54 (1) 43 (1) 5855 (108) 189 (4) 39 (1) probable amino acid permease  
a
 The PA ID numbers were taken from the PAO1 genome annotation project (www.pseudomonas.com).  
b
 GeneChip raw data are mean values from two independent sets of cultures. Cells were grown in minimal medium P supplemented with 20 mM of the following 
supplements as indicated: Glu, glutamate; Arg, L-arginine; Put, putrescine; GABA, -aminobutyrate; Lys, L-lysine; Cad, cadaverine; AMV, -aminovalerate. 
Fold changes are in parenthesis. 
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Table 1.6. L-lysine inducible genes selected from DNA microarray analysis 
 
    Signal Value
b
   
PA ID
a
 Gene  Glu Glu Glu Glu Glu Glu      Annotations  
    Glu Arg Put GABA Lys Cad AMV   
          PA0446 
 
169 45(0) 127(1) 66(0) 1263(7) 1699(10) 2294(14) Predicted acyl-CoA transferase 
PA0447 gcdH  167 134(1) 141(1) 189(1) 9747(58) 7201(43) 9184(55) glutaryl-CoA dehydrogenase 
          PA2662 
 
64 144(2) 107(2) 60(1) 600(9) 525(8) 617(10) conserved hypothetical protein 
PA2663 ppyR 49 140(3) 96(2) 54(1) 923(19) 614(13) 939(19) psl and pyoverdine operon regulator 
PA2664 fhp 14 6(0) 15(1) 6(0) 1602(114) 618(44) 1490(106) flavohemoprotein 
          
PA1027 amaA 100 20(0) 124(1) 76(1) 1230(12) 197(2) 238(2) 
-aminoadipate -semialdehyde 
dehydrogenase
PA1028 amaB 87 243(3) 109(1) 98(1) 483(6) 231(3) 144(2) L-Pipecolate oxidase 
          PA4181 
 
171 323(2) 174(1) 164(1) 5721(33) 432(3) 385(2) hypothetical protein of unknown function 
PA4182 
 
189 306(2) 252(1) 179(1) 8959(47) 423(2) 457(2) hypothetical transcriptional factor 
          PA4364 
 
56 58(1) 38(1) 58(1) 2448(44) 125(2) 30(1) hypothetical protein of unknown function 
PA4365   54 70(1) 52(1) 26(0) 2304(43) 181(3) 111(2) probable lysine exporter 
 
a
 The PA ID numbers were taken from the PAO1 genome annotation project (www.pseudomonas.com).  
b
 GeneChip raw data are mean values from two independent sets of cultures. Cells were grown in minimal medium P supplemented with 20 mM of the following 
supplements as indicated: Glu, glutamate; Arg, L-arginine; Put, putrescine; GABA, -aminobutyrate; Lys, L-lysine; Cad, cadaverine; AMV, -aminovalerate. 
Fold changes are in parenthesis. 
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In contrast, a group of 11 genes in five putative operons was subjected to specific induction 
by L-lysine but not L-arginine (Table 1.6). Among them, the PA0446-PA0447 and PA2662-
PA2664 operons were inducible either by L-lysine, cadaverine or AMV. PA0446 encodes a 
putative acyl-CoA transferase, and PA0447 (gcdH) a glutaryl-CoA dehydrogenase. This locus 
might be involved in lipid and amino acid catabolism (96). On the other hand, PA2662-PA2664 
operon seems related to nitric oxide (NO) detoxification. PA2664 (fhp) encodes a 
flavohemoglobin with NO reductase activity under anaerobic conditions and NO dioxygenase 
activity under aerobic conditions (2, 80). PA2663 (ppyR) encodes a membrane sensor protein. 
Upon ppyR inactivation, defective biofilm formation and quorum sensing were reported in P. 
aeruginosa (3). And PA2662 encodes a membrane protein predicted for response to NO. 
 
Among the lysine inducible genes, six genes in three operons were specifically inducible 
by L-lysine but not by its downstream metabolites cadaverine or AMV (Table 1.6). The first 
operon, PA1027-PA1028, is the counterpart of amaA-amaB, encoding important enzymes of the 
D-lysine catabolic pathway in P. putida (82, 84). 2-ketolysine derived from lysine deamination is 
spontaneously converted into 1-piperidine-2-carboxylate, a cyclic form of higher stability (36). 
In P. putida, 1-piperidine-2-carboxylate derived from D-lysine deamination leads to L-
pipecolate biosynthesis by DpkA which in turn is channeled to aminoadipate by AmaB and 
AmaA (82, 84). AmaB, a FAD-dependent oxidoreductase, converts L-pipecolate into 1-
piperidine-6-carboxylate, and AmaA, an aldehyde dehydrogenase, synthesizes 2-aminoadipate 
from 1-piperidine-6-carboxylate. The existence of the ama locus in P. aeruginosa is intriguing 
since the dpkA gene for L-pipecolate synthesis is absent on the chromosome. Possible 
explanation might be a cross reaction of AmaA with 1-piperidine-2-carboxylate. However, no 
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growth on lysine in lysine decarboxylase ldcA deficient strain suggested limited role of AmaA 
and AmaB in lysine utilization.  The second operon, PA4181-PA4182, encodes hypothetical 
proteins of unknown function. PA4182 might be a transcriptional regulator with a FMN-binding 
domain. More studies are required to investigate the functions of these genes. The third and last 
operon of this group, PA4364-PA4365, encodes a hypothetical protein of unknown function and 
a putative lysine exporter with six transmembrane helices. This LysE type transporter is 
predicted to excrete excess lysine from the cell as in C. glutamicum (99).  Induction of this 
exporter may suggest that L-lysine were taken up but needed to be pumped out due to 
intracellular accumulation.  
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1.4   DISCUSSION 
 
The bottleneck of lysine catabolism. The most intriguing finding in this study was that 
both lysine uptake and degradation are inducible by L-arginine and show no response to L-lysine. 
The arginine dependent ldcA expression was revealed from its promoter activities; and electro-
mobility shift assays also revealed interactions of the arginine-responsive regulator ArgR to its 
putative binding site in the promoter region. The lack of lysine-responsive induction on ldcA is 
likely the major limiting factor of growth on L-lysine. Growth of P. aeruginosa on L-lysine 
exhibited a long lag phase of 44±2 hours. In comparison, growth on cadaverine, the 
decarboxylation product of L-lysine by LdcA, has normal lag phase. Indeed putting ldcA under 
control of the constitutive lac promoter in a plasmid improved growth significantly.  
 
Conditions that increase the level of intracellular arginine and ArgR could also induce ldcA 
expression, and hence promote a better growth on L-lysine. While ldcA was induced under these 
conditions, at least two ABC transporter systems for L-arginine were also increased (aotJQMP 
and PA5152-PA5155). Interestingly, counterparts of these two systems in P. putida KT2440 have 
been reported as candidate L-lysine transport systems in recent studies (83). PP0283-PP0280 
and the PP4486-PP4482 show high similarities in gene organization as well as in amino acids 
sequences (82% and 76% respectively) with P. aeruginosa, PA5152-5155 and aotJQMP-argR 
loci. Together with LdcB, a candidate lysine/cadaverine antiporter, all three candidate transport 
systems in P. aeruginosa are regulated by ArgR in response to L-arginine but not to L-lysine. 
This may explain the lack of lysine-inducible uptake as another limiting factor for growth on L-
lysine in P. aeruginosa PAO1. 
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The lysine decarboxylase LdcA is conserved among pseudomonads. In the 
Pseudomonas Genome Database (www.pseudomonas.com), orthologs of LdcA can be found in 
strains of P. entomophila, P. fluorescens, P. mendocina, P. putida, and P. stutzeri, but not in P. 
syringae. For P. putida KT2440, the corresponding gene (PP4140) contains an authentic 
mutation that causes a frame shift of the translated product. While gene organization of ldcA and 
its upstream dnaQ encoding the epsilon subunit of DNA polymerase III is conserved among 
these strains, the downstream ldcB can only be found in strains of P. aeruginosa. In conclusion, it 
is reasonable to predict that most species of pseudomonads possess the L-lysine decarboxylase. 
 
Other pathways of lysine catabolism. The aruH gene encodes for an L-arginine and L-
lysine:pyruvate transaminase (104). Contribution of this enzyme in lysine utilization as the sole 
nitrogen source can only be detected when constitutively expressed from a plasmid. However, 
AruH may not have any physiological implication on lysine catabolism in PAO1 as the ldcA 
mutant showed no growth on L-lysine as the sole source of carbon or nitrogen. Perhaps it was 
because of low L-lysine uptake and low affinity of AruH on L-lysine. 
 
The aruH and aruI genes encode the first two enzymes of the arginine transaminase 
pathway in P. aeruginosa (104). While aruHI are conserved in P. putida, an extra gene encoding 
an amino acid racemase is located between aruH and aruI of this organism. The amino acid 
sequence of this racemase contains a predicted signal peptide at the N-terminus, suggesting its 
secretion to the periplasm. This implies the role of this additional gene as the racemase to convert 
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L-lysine into D-lysine before channeled into the D-lysine catabolic pathway in P. putida (10, 34, 
82). 
 
P. aeruginosa can only utilize D-lysine as nitrogen source but not carbon source by the 
FAD-dependent dehydrogenase DauA (52). Transamination of L-lysine by AruH or D-lysine by 
DauA leads to -keto--aminohexanoate which is spontaneously converted into its cyclic form 
Δ1-piperideine-2-carboxylate at physiological pH (40). Recent studies in P. putida suggests 
further degradation of this molecule into L-pipecolate by the reductase DpkA (PP3591) (84). 
However, viability of this pathway is still undefined in P. aeruginosa since dpkA orthologue is 
not present on the chromosome, corresponding biochemical reaction cannot be detected, and no 
growth is detectable using D-lysine as carbon source (19). 
 
Lysine decarboxylation is the main route of L-lysine catabolism in P. aeruginosa. 
With the purified enzyme, I demonstrated that LdcA is an L-lysine decarboxylase with no 
activity toward L-arginine. Genetic studies also indicated that ldcA is essential for L-lysine 
utilization in P. aeruginosa. Therefore, I concluded that the lysine decarboxylase LdcA is the 
enzyme responsible of the pivotal step of L-lysine catabolism in this organism. 
 
 Transcriptome analysis of arginine and putrescine unraveled lysine and cadaverine 
catabolic pathways. It had been very confusing the initial studies of the lysine decarboxylase 
pathway gene ldcA since it is highly induced by arginine in the DNA microarray data. And none 
of the genes for lysine utilization identified in this study were inducible by lysine. Without the 
strong arginine background of our laboratory, it would not be possible to discover the arginine 
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control on lysine utilization through ArgR. Similarly, I also encountered difficulties analyzing 
genome-wide responses to exogenous cadaverine. No obvious hints of catabolic genes for 
cadaverine were able to be picked up from this set of DNA microarrays. Fortunately, I performed 
transcriptome analysis using putrescine, a similar compound derived from ornithine and/or 
arginine, where candidate genes for polyamine -glutamylation were noticed (13). This 
motivated me to propose putrescine and cadaverine degradation through -glutamylation 
pathway in P. aeruginosa which will be described in Chapter Two of this thesis.  
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CHAPTER TWO 
 
 
CADAVERINE AND PUTRESCINE CATABOLISM THROUGH -GLUTAMYLATION 
IN PSEUDOMONAS AERUGINOSA PAO1 
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2.1    INTRODUCTION  
 
Cadaverine and putrescine are diamines involved in a wide spectrum of physiological 
functions from prokaryotic to eukaryotic cells (45, 90), and intracellular concentrations of these 
compounds are finely tuned through biosynthesis, degradation and transport (14). In microbes, 
putrescine and cadaverine are synthesized directly from decarboxylation of ornithine (speC) and 
lysine (ldcA) respectively (12, 72). Alternatively, endogenous putrescine can also be generated 
through arginine and agmatine degradation (13, 73). On the other hand, exogenous putrescine 
and cadaverine can be taken as carbon and nitrogen sources by many bacteria including P. 
aeruginosa (12, 13, 93). It was first reported in E. coli that putrescine is degraded through the -
glutamylation pathway (43, 44). This pathway consists of four consecutive reactions with 
consumption of ATP in the first step for -Glu-putrescine biosynthesis (Figure 2.1).  
 
In order to understand how P. aeruginosa responds to exogenous polyamines, DNA 
microarray experiments had been conducted to get snapshots of gene expression at the 
exponential phase of growth (13). A group of redundant genes were identified for -
glutamylation and were shown essential for polyamine utilization in P. aeruginosa (13, 105). 
Different from E. coli, the -glutamylation pathway is more complex by the existence of multiple 
homologous enzymes with redundant specificity toward different polyamines for a larger 
metabolic capacity in P. aeruginosa (105).  
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Figure 2.1. Proposed cadaverine catabolic pathway in P. aeruginosa  
 
Proposed cadaverine catabolism by the -glutamylation pathway was shown above. The Pau 
proteins for polyamine utilization were marked. For putrescine glutamylation, PauA1, PauA2 
and PauA5 catalyze the first step of the pathway. Also shown were the enzymes GabT, GabT2, 
and GabD, for AMV and GABA degradation. 
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Alternatively, putrescine was proposed to be degraded without -glutamylation through a 
traditional transaminase-dehydrogenase pathway (13). PA0299 (SpuC) and PA5312 (PauC/KauB) 
were proposed as putrescine:alanine transaminase and aldehyde dehydrogenase for direct 
degradation of putrescine into -aminobutyrate (GABA) due to the growth deficiency on 
putrescine of the corresponding mutant strains (13, 59). However, deletion mutants devoid of the 
glutamylation pathway cannot grow on polyamines (105). Therefore the direct transaminase-
dehydrogenase pathway has limited contribution in polyamine utilization, and PA0299 and 
PA5312 were proposed to play their roles after polyamine glutamylation.  
 
Putrescine and cadaverine were proposed to be degraded into -aminobutyrate (GABA) and 
-aminovalerate (AMV), respectively. To serve as carbon sources, subsequent reactions are 
required to degrade GABA into succinate and AMV into glutarate. Based on similarities in 
chemistry, pathways with common enzymes for the utilization of GABA and AMV were 
proposed (12, 42).  
 
This study was undertaken to investigate the importance of the -glutamylation pathway for 
putrescine and cadaverine utilization in P. aeruginosa. Essential Glu-putrescine and Glu-
cadaverine synthetases were identified by genetics approach. Different from putrescine, carbon 
catabolite repression was detected for cadaverine utilization. A regulatory protein of the cupin 
family, PauR, was identified revealing regulation on putrescine/cadaverine glutamylation and 
GABA/AMV degradation through conformational changes. The gabD, gabT and gabT2 genes 
for GABA degradation were investigated for AMV degradation into glutarate. In addition to 
common catabolic pathways, a newly identified ABC transport system agtABCD under 
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regulation of a two-component system agtSR were proven to contribute in both GABA and AMV 
utilization. The genetics and regulatory aspects of the -glutamylation pathway for putrescine 
and cadaverine utilization in this organism were investigated in this study.  
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Table 2.1. Strains and plasmids 
 
Strain or plasmid Genotype or description
a
  Source 
E. coli strains   
DH5 F
-Φ80dlac ∆M15 ∆(lacZYA-argF)U169 deoR recA1 
endA1 hsdR17 (rK
-
 mK
-
) supE44 λ- thi-1gyrA96 relA 
Bethesda 
Research 
Laboratories 
TOP10 F- mcrA (mrr-hsdRMS-mcrBC) 80lacZM15 
DlacX74 recA1 araD139 (ara-leu)7697 galU galK 
rpsL (Sm
r
) endA1 nupG 
Invitrogen 
SM10 thi-1 thr leu tonA lacY supE recA::RP4-2-Tc::Mu 
(Km
r
) 
(91) 
P. aeruginosa strains   
PAO1 Wild type (27) 
PAO1-Sm
r
 Spontaneous Sm
r
 mutant strain of PAO1 (35) 
PAO5725 
pauA1-A6 (PA0296; PA0298; PA1566; 
PA2040::Gmr; PA3356; PA5522)   
This study 
PAO5722 pauR::Gm
r
 This study 
PAO5701 gabD::Tc
r
 (13) 
PAO5703 gabT::Tc
r
 (13) 
PAO5708 gabT2::Gm
r
 (13) 
PAO5704 gabT/T2 (gabT::Tc
r
; gabT2::Gm
r
) (13) 
H103 Wild type (51) 
PAO5723 agtS::lux, ID:PAO1_lux_23_C9 (51) 
PAO5724 agtA::lux, ID: PAO1_lux_25_F4 (51) 
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Plasmids 
  
pRTP1 Amp
r 
Sm
s 
conjugation vector (95) 
pGM1 Amp
r
 Gm
r
; gentamicin resistance gene cassette with 
omega loop on both ends 
(88) 
pQF50 bla; lacZ transcriptional fusion vector (18) 
pQF52 bla; lacZ translational fusion vector derived from 
pQF50 
(76) 
pGU101 spuA::lacZ (for pauA2) translational fusion of pQF52  (59) 
pGU102 pauA1(spuI)::lacZ translational fusion of pQF52 (59) 
pHT2040 pauA4::lacZ transcriptional fusion of pQF50 This study 
pHT3356 pauA5::lacZ transcriptional fusion of pQF50 This study 
pHT0603 agtA::lacZ transcriptional fusion of pQF50 This study 
pMH105 gabD::lacZ translational fusion of pQF52 (29) 
pHT0265-1 palindrome-gabD::lacZ transcriptional fusion of 
pQF50 
This study 
pHT0265-2 No palindrome-gabD::lacZ transcriptional fusion of 
pQF50 
This study 
pHT5313 gabT2::lacZ transcriptional fusion of pQF50 (13) 
pBAD-His6 Modified protein expression vector derived from 
pBAD-HisA 
(52) 
pBAD-PauR 6 x His-tagged PauR protein expression vector This study 
pBAD-GabD 6 x His-tagged GabD protein expression vector This study 
pBAD-AgtR 6 x His-tagged AgtR protein expression vector This study 
 
a
 Sm
r
, streptomycin resistance; Km
r
, kanamycin resistance; Gm
r
, gentamicin resistance; Tc
r
, 
tetracycline resistance; Amp
r
, ampicillin resistance; Sm
s
, streptomycin sensitive.
 46 
2.2    MATERIALS AND METHODS 
 
Bacterial strains, plasmids, media, and growth conditions. Mutant strains of the agt locus 
are from the lux transposon mutant library courtesy of Dr Hancock at University of British 
Columbia, Vancouver, B.C., Canada (pseudomutant.pseudomonas.com). Luria-Bertani (LB) 
medium was used with the following
 
supplements as required: ampicillin at 100 µg ml
-1
, 
 
tetracycline at 12.5 µg ml
-1
, gentamicin at 10 µg ml
-1
, 5-bromo-4-chloro-3-indolyl-β-D-
galactopyranoside (X-Gal) at 0.03 % (wt/vol) for E. coli; and carbenicillin at 100 µg ml
-1
, 
streptomycin at 500 µg ml
-1
, tetracycline at 100 µg ml
-1 
and gentamicin at 100 µg ml
-1
 for P. 
aeruginosa. Minimal medium P (27) containing the indicated carbon sources at 20 mM and 
nitrogen sources at 5 mM was used for the growth of P. aeruginosa.  
 
DNA Microarray. DNA microarray experiment was conducted as described in Chapter One. 
Data was deposited in the Gene Expression Omnibus (GEO) database (GSE9926). 
 
Construction of a pauR knockout mutant. For deletion mutants, two flanking regions of 
the targeted gene were PCR amplified and cloned into pRTP1 using primers: pauR1F 5‟-CGG 
GAT CCC GAT CAG AAA TTT GCG GGC GTG G-3‟; pauR1R 5‟- CGG AAT TCC GGC 
GCG GTG TCC ATG CGC CTG-3‟; pauR2F 5‟- CGG AAT TCC GGT CGA TCA GTT CGT 
CTG CCT -3‟; pauR2R 5‟- CCA AGC TTG GGG TGC TCG TCT GCA AAC CAT -3‟. The 
PCR products were cloned into pRTP1. A cassette carrying gentamicin-resistance gene from 
pGM1 was inserted into the conjunction of the two DNA fragments (88). For gene replacement, 
E. coli SM10 was served as the donors in biparental mating with PAO1-Sm
r
 (21). The desired 
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knockout mutants were selected on LB plates containing streptomycin and either gentamicin or 
tetracycline, and the mutation was confirmed by PCR.  
 
Construction of lacZ fusions. Plasmids pGU101, pGU102 and pHT5313 were used to measure 
pauA2, pauA1 and gabT2 promoters activities, respectively (13, 59). Regulatory regions of 
gabDT, pauA5 (PA3356), pauA4 (PA2040) and agtA (PA0603) were amplified by PCR from the 
genomic DNA of P. aeruginosa PAO1 using the following primers: Pgab_F, 5‟-GGA TTC GTT 
TGA GAT TTC AAA CGC CCC-3‟; Pgab_palindrome_R, 5‟-GGG GCG TTT GAA ATC TCA 
AAC GAA TCC-3‟; Pgab_no palindrome_R, 5‟-TCT CAA ACG AAT CCT AGG GCC-3‟; P 
pauA5_F, 5‟-GGT GG A TCC GAG AAT CAA CGG CAG TAC TC-3‟; PpauA5_R, 5‟-GGT 
AAG CTT GAT GCA TTG CAG CAG CAC GCCA-3‟; PpauA4_F, 5‟-GGT GGA TCC TTG 
AAC GAT CTT GCT CTT CGT ATC-3‟; PpauA4_R, 5‟-GGT AAG CTT GAA GGA ACA GGC 
TCG GCT CAG-3‟; PagtA_F, 5‟-GGT GGA T CC GCA AGC TCG ACG AGC TGA AGC CCT 
ATA TC-3‟; PagtA_R, 5‟- GGT AAG CTT GAG TCT CGG CCA TAA CCG CAC CTT TGT 
TC-3‟. PCR products were cloned into pQF50 and confirmed by DNA sequencing. 
 
Measurements of LacZ enzyme activity.  The cells were grown in the minimal medium P 
containing carbon and nitrogen sources as indicated. Cells in the mid-log phase when the optical 
density at 600 nm reached 0.7 were harvested by centrifugation, and then passed through a 
French press cell at 8500 lb/in
2
 The cell debris were removed by centrifugation at 20,000 g for 
10 min, at 4C, and protein concentrations in the crude extracts were determined by the Bradford 
method (5), using bovine serum albumin as standard. The levels of β-galactosidase activity were 
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measured at 37˚C using o-nitrophenyl-β-galactopyranoside as the reaction substrate, and the 
formation of o-nitrophenol was determined by spectrophotometry at 420 nm (64). 
 
Overexpression and purification of the histidine-tagged PauR and AgtR proteins. Full-
length pauR and agtR were amplified from the genomic DNA of P. aeruginosa using the 
following primers: agtR F 5‟- GTG ATC CGA GTC CTG GTC GCT GAA G -3‟, agtR R 5‟- 
GAG GAA TTC TGT CAG AGC AGG CGG TGC TCC ATC-3‟, pauR F 5‟- GAC GTC GGT 
GCT CGT CTG CAA ACC -3‟, pauR R 5‟- GAG GAA TTC TTG TGC TTC AGG TCA GAA 
ATT TGC-3‟. The PCR products were digested with EcoRI restriction endonuclease and 
assembled onto the SmaI and EcoRI sites of pBAD-His6, a modified pBAD expression vector 
(52, 103). Recombinant proteins were expressed by arabinose induction in Escherichia coli 
TOP10 (Invitrogen life technologies). Cell extract was obtained by passing through a French 
pressure cell at 8,500 lb/in
2
. Soluble fraction was subjected to protein purification using HisTrap 
HP column (GE Healthcare) following manufacturer‟s instructions. Protein purity was analyzed 
by SDS PAGE and concentration was determined
 
by the method of Bradford (5). 
 
Glutaraldehyde crosslinking. Purified His-PauR was subjected to glutaraldehyde treatment 
in 20mM HEPES buffers at pH 7.5. Reaction mixtures with 25µg of purified His-PauR in a total 
volume of 100 µl were treated with 5 µl of 2.3% freshly prepared solution of glutaraldehyde for 
2 minutes at 25
o
C followed by 3 minutes at 37
o
C. The reaction is terminated by addition of 10 µl 
of 1 M Tris-HCl (pH 8.0).  Diamines, GABA or AMV are incorporated into the reaction mixture 
at 1mM concentration either prior glutaraldehyde treatment or after quenching with Tris buffer. 
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Cross-linked proteins were analyzed by SDS-polyacrylamide gels electrophoresis and visualized 
by ProtoBlue Safe staining (National Diagnostics). 
 
Electrophoretic mobility shift assays. DNA fragments covering regulatory regions were 
PCR amplified from the genome using the same primers as for the construction of the cognate 
promoter-lacZ fusions. For pauA1/spuA divergent promoters, the following primers were used: 
Pspu F 5‟-GTA CCG ACA TGA TGC AAC AC -3‟ and Pspu R 5‟- CAG GCG AGA CAT GAG 
ACA C -3‟. For radioactively labeled DNA probes, [γ-32P] dATP were incorporated by 
polynucleotide kinase. DNA probes (0.2 ng) were allowed to interact with different 
concentrations of purified proteins in a 20 μl reaction mixture containing 50 mM Tris-HCl (pH 
8), 50 mM KCl, 1mM EDTA, 5% (v/v) glycerol, and 150 μg/ml acetylated bovine serum 
albumin. A smaller DNA fragment amplified from the lipA promoter region was used as negative 
control for non-specific binding. The reaction mixtures were incubated for 30 min at room 
temperature before applying to a 4% native polyacrylamide gel in 0.5X TBE (pH7.5) buffer. 
After being dried, the gel was auto-radiographed by exposure to a phosphorimager plate, scanned 
using FLA-7000 version 1.1, and analyzed by Multi Gauge version 3.0 (FUJIFILM). For non-
radioactive DNA probes, 1 ng of DNA was used in the reaction mixture and visualized from the 
polyacrylamide gel by SYBR green I staining (Invitrogen) followed by Omega UltraLum 
imaging system with 473 nm excitation and 520 nm emission wave lengths. 
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2.3   RESULTS AND DISCUSSION 
 
Putrescine and cadaverine are the inducer molecules of the -glutamylation pathway. 
For the first step of the -glutamylation pathway, seven glutamyl-polyamine synthetases 
(PauA1~PauA7) were identified in P. aeruginosa based on sequence homology to E. coli 
glutamyl-putrescine synthetase PuuA. Parallelly, DNA microarray experiment showed 
PauA1~PauA6 (not PauA7) were inducible by either putrescine or spermidine (Table 2.2). To 
confirm involvement of these enzymes in polyamine utilization, a series of deletion knockouts 
with different combinations of pauA(s) was performed. Based on these genetics studies, the -
Glu-polyamine synthetases PauA1, PauA2 and PauA4 were proven essential for growth on 
putrescine, and PauA1, PauA4 and PauA5 for cadaverine (Figure 2.1, Table 2.3).  
 
To determine the inducer molecule of the -glutamylation pathway, the pauA promoter 
activities in response to exogenous putrescine and cadaverine were measured in the wild type 
PAO1 harboring pGU101 (PpauA2::lacZ), pGU102 (PpauA1::lacZ), pHT2040 (PpauA4::lacZ) or 
pHT3356 (PpauA5::lacZ). As shown in Figure 2.2, tested pauA(s) promoters were inducible by 
either putrescine (>5 folds) or cadaverine (>2.5 folds) in glucose/ammonia minimal medium.  
Then I compared the expression profile in the PAO5725 mutant strain where all six -Glu-
polyamine synthetase genes (pauA1-pauA6) were deleted. As shown in the same graphs, while 
the basal expression levels of these four pauA promoters were similar in PAO1 and PAO5725 
induction by putrescine and cadaverine were further enhanced (except pauA5 promoter) in 
PAO5725 due to internal accumulation of polyamines in this mutant. These data indicate that 
putrescine and cadaverine are the inducer molecules of the -glutamylation pathway. 
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Table 2.2. Genes for polyamine -glutamylation pathway 
    Signal Value
b
   
PA ID
a
 Gene 
Name 
 Glu Glu Glu Glu  Glu Descriptions 
    Glu Put GABA Cad AMV Spd   
PA0296 pauA1/spuI 1113 7613 (7) 4045 (4) 1055 (1) 1211 (1) 5044 (5) glutamylpolyamine synthetase, pauA4 (PA2040) homolog 
PA0297 pauD1/spuA 275 1663 (6) 1260 (5) 341 (1) 214 (1) 1926 (7) putative γ-glutamyl hydrolase  
PA0298 pauA2/spuB 582 2625 (5) 1892 (3) 459 (1) 502 (1) 4244 (7) glutamylpolyamine synthetase 
PA0299             spuC 1203 6179 (5) 4112 (3) 2331 (2) 2893 (2) 7115 (6) aminotransferase  
PA0534 pauB1 26 398 (15) 555 (21) 883 (34) 250 (10) 42 (2) FAD-dependent oxidoreductase 
PA1565 pauB2 58 42 (1) 62 (1) 140 (2) 175 (3) 2111 (36) FAD-dependent oxidoreductase 
PA1566 pauA3 23 13 (1) 46 (2) 22 (1) 19 (1) 2057 (89) glutamylpolyamine synthetase  
PA1742 pauD2 366 1605 (4) 2292 (6) 606 (2) 685 (2) 762 (2) putative γ-glutamyl hydrolase 
PA2776 pauB3 194 2555 (13) 5078 (26) 186 (1) 327 (2) 460 (2) FAD-dependent oxidoreductase 
PA3356 pauA5 591 3232 (5) 1687 (3) 1635 (3) 1960 (3) 3240 (5) glutamylpolyamine synthetase 
PA5309 pauB4 398 1007 (3) 1316 (3) 690 (2) 703 (2) 477 (1) FAD-dependent oxidoreductase 
PA5508 pauA7 128 119 (1) 155 (1) 156 (1) 272 (2) 79 (1) glutamylpolyamine synthetase 
PA5522 pauA6 116 591 (5) 411 (4) 265 (2) 282 (2) 566 (5) glutamylpolyamine synthetase 
PA5312 pauC/kauB 922 7744 (8) 5130 (6) 1392 (2) 1256 (1) 5540 (6) aldehyde dehydrogenase 
PA5302 dadX 53 2770 (52) 359 (7) 468 (9) 297 (6) 1947 (37) alanine racemase 
PA5303 
 
105 3934 (37) 493 (5) 438 (4) 359 (3) 2826 (27) 
 
PA5304 dadA 165 5682 (34) 755 (5) 793 (5) 685 (4) 3842 (23) D-alanine dehydrogenase 
PA0265 gabD 448 6923 (15) 6247 (14) 1889 (4) 2161 (5) 4434 (10) succinate-semialdehyde dehydrogenase 
PA0266 gabT 721 9244 (13) 7800 (11) 3199 (4) 3617 (5) 6136 (9) 4-aminobutyrate aminotransferase 
PA5313 gabT2 144 4226 (29) 1426 (10) 107 (1) 146 (1) 2095 (15) pyridoxal-dependent aminotransferase 
PA5314   91 2298 (25) 666 (7) 104 (1) 88 (1) 1385 (15) hypothetical protein 
a
 The PA ID numbers were taken from the PAO1 genome annotation project (www.pseudomonas.com).  
b
 GeneChip raw data are mean values from two independent sets of cultures. Cells were grown in minimal medium P supplemented with 20 mM of the following 
supplements as indicated: Glu, glutamate; Put, putrescine; GABA, -aminobutyrate; Lys, L-lysine; Cad, cadaverine; AMV, -aminovalerate; Spd, spermidine. 
Fold changes are in parenthesis. 
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Table 2.3. Growth phenotypes of pauA mutants on polyamines, GABA, and AMV 
  
Strain 
Carbon Sources* 
Cad AMV Put GABA Spd 
WT + ++ ++ ++ ++ 
pauA2 + ++ ++ ++ - 
pauA1 ++ ++ ++ ++ ++ 
pauA4 ++ ++ ++ ++ ++ 
pauA5 ++ ++ ++ ++ ++ 
pauA1/4 ++ ++ + ++ ++ 
pauA1/5 + ++ ++ ++ ++ 
pauA4/5 ++ ++ ++ ++ ++ 
pauA1/2/4 ++ ++ - ++ ++ 
pauA1/4/5 - ++ + ++ ++ 
pauA1-6 - ++ - ++ - 
 
* Cells were grown on MMP media agar plates with the indicated 
supplements as the sole source of carbon: Cad, cadaverine; AMV, -
aminovalerate; Put, putrescine; GABA, -aminobutyrate; Glc, glucose. All 
supplements were added to 10mM. Ammonia was added to 5 mM as the 
sole source of nitrogen. Growth was recorded in 3 days at 37C. ++, 
growth after 1 day; +, growth after 2 days; -, no detectable growth after 3 
days. All unmarked deletion mutants were derived from PAO1. 
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Figure 2.2. Expression profile of pauA promoters in P. aeruginosa PAO1. 
Specific activities of -galactosidase expressed from pGU102 for the pauA1 promoter, 
pGU101 for the pauA2 promoter, pHT2040 for the pauA4 promoter, or pHT3356 for the 
pauA5 promoter, were measured from the host strains wild type PAO1 (solid bars) and 
pauA1-6 mutant PAO5725 (empty bars) devoid of six glutamyl-polyamine synthetase 
genes. The cells were grown in glucose/ammonia (GN) minimal medium in the presence 
or absence of putrescine (P) and cadaverine (C). 
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Figure 2.3. Glucose/ammonia effect on expression profile of pauA promoters 
 
Specific activities of -galactosidase expressed from pauA promoter-lacZ fusions (same 
constructs as in Figure 2.2) were measured from the host strain wild type PAO1. The cells 
were grown in minimal medium P in the presence of putrescine (P) or cadaverine (C). 
Empty bars represent expression levels when 10 mM putrescine or cadaverine was used as 
sole source of nutrient for growth. Solid bars show repression on cadaverine utilization by 
10 mM glucose and 5 mM ammonia (GN) as background nutrients while PauA expression 
with putrescine remained unaffected.  
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Catabolite repression on cadaverine utilization. Cadaverine and putrescine are diamines 
of similar chemical structure and molecular weight. However, there was a longer lag phase (1 
day) for growth on cadaverine compared to putrescine. Additionally, it was noted that even 
pauA1, pauA4 and pauA5 are essential for cadaverine utilization (Table 2.3), pauA5 was only 
slightly induced (3 folds) and pauA1 and pauA4 were not induced by exogenous cadaverine in 
the DNA microarray data where the cells were grown in glutamate minimal media (Table 2.2). 
To understand the possible effect of glutamate and other nutrient sources on these expression 
patterns, pauAs expressions at the exponential growth phase were monitored in wild type PAO1 
using the same promoter-lacZ fusions as in the previous section. As shown in Figure 2.3, while 
all pauA promoter activities with putrescine remained unaffected by background nutrients, 
expression levels with cadaverine were significantly reduced when glucose and ammonia were 
added into the media. Among these four pauA promoters, pauA1 and pauA5 promoters showed 
higher specific activities from the -galactosidase assays with approximately 4 folds of 
difference when cadaverine was used as sole source of carbon and nitrogen. On the other hand, 
pauA2 and pauA4 promoters showed lower specific activities but with high fold changes (18 and 
8 folds respectively) when compared to expression levels in glucose and ammonia minimal 
media. Similar phenomenon of repression was observed using glutamate minimal media (data 
not shown) suggesting strong catabolite repression for cadaverine utilization in this organism.   
 
 Regulation of the -glutamylation pathway. Based on studies in E. coli, -glutamylation 
pathway is negatively regulated by PuuR (44). The puuR counterpart in P. aeruginosa, PA5301, 
was replaced by a gentamicin resistance cassette in the mutant strain PAO5722. While there is no 
significant effect on growth in either LB or glutamate (data not shown), the four pauA promoters 
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(from previous sections) showed constitutive expression levels in PAO5722 (Figure 2.4). This 
strongly suggests a regulatory role of PA5301 in the pathway thus I designated this gene as 
polyamine utilization regulator, pauR. 
 
Binding of PauR on pauA promoters were successfully proven in vitro. PauR was purified to 
homogeneity as described in Methods and subjected to electrophoretic mobility shift experiments 
using the same regulatory regions of the four pauA genes as in expression measurements. As 
shown in Figure 2.5A, clear binding on pauA1-2 (divergent promoters), pauA4 and pauA5 were 
detected with high affinity. However, when I tested for effect of polyamines by adding 1 mM of 
putrescine or cadaverine in the reaction, no apparent effect on the binding was detectable 
(Figures 2.5B and 2.5C). This intrigued me, so I performed PauR (24 KDa) glutaraldehyde 
crosslinking analysis to see changes in PauR in response to polyamines. As shown in Figure 
2.5D, distinct PauR homo-dimmer formation was detected after crosslinking. When putrescine or 
cadaverine was added into the reaction, the monomeric and dimeric bands became diffused with 
a slight increase in molecular weight on SDS PAGE. This change is specific to putrescine and 
cadaverine but not to diaminopropane, a diamine with shorter methylene chain. As controls, 
polyamines were added after the crosslinking reaction and no change was detectable in these 
samples indicating that band diffusion was not due to the presence of polyamines during 
electrophoresis. This data suggests that PauR regulates the -glutamylation pathway through 
conformational changes in response to putrescine/cadaverine. 
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Figure 2.4. Effects of pauR on expression profiles of the pauA promoters 
 
Specific activities of -galactosidase expressed from pauA promoter-lacZ fusions (same 
constructs as in Figure 2.2) were measured from the host strains wild type PAO1 (solid 
bars) and pauR mutant PAO5722 (empty bars). The cells were grown in minimal medium 
P supplemented with glucose (G) as the sole source of carbon, and putrescine (P), 
cadaverine (C), or ammonia (N), as the sole source of nitrogen. 
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Figure 2.5. PauR binding on pauA promoters. 
 
A, B and C. PauR binding on pauA1-2, pauA4 and pauA5 promoters. Interactions of 
purified His-PauR with radioactively labeled pauA promoter regions were demonstrated 
by the electrophoretic mobility shift assays. No evident effects of polyamines on PauR 
binding were detectable by adding 1mM of putrescine or cadaverine in the reaction 
mixture, gel, and running buffer (B and C). D. PauR conformation change in response 
to putrescine and cadaverine. PauR showed distinct dimmer formation after 
glutaraldehyde crosslinkage (lane 3). Putrescine and cadaverine, but not diaminopropane, 
seemed to induce conformational changes (lanes 4 to 6).  As negative controls, 
polyamines were added after the termination of crosslinking reaction (lanes 7 and 8). No 
glutaraldehyde was added in the reactions of lanes 9 and 10.  
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Common enzymes for GABA and AMV catabolism. GABA and AMV are the 
corresponding downstream metabolites of putrescine and cadaverine in the -glutamylation 
pathway (Figure 2.1) (12, 13, 42). Based on previous reports of our laboratory, gabDT and 
gabT2 code for two transaminases and a succinic semialdehyde dehydrogenase essential for the 
two-step degradation of GABA into succinate (13). Due to similarities in chemistry, overlaps in 
putrescine/cadaverine catabolic pathways may extend to GABA/AMV degradation. To prove 
this hypothesis, I tested the GABA catabolic genes for AMV. As expected, growth on AMV was 
completely depleted in gabT/T2 double mutant PAO5704 suggesting essential roles of these 
transaminases in both GABA and AMV utilization (Table 2.4). In contrast, leaky growth of 
gabD mutant PAO5701 on AMV suggests alternative route for glutarate semialdehyde 
degradation.  
 
Two promoter-lacZ fusions pMH105 (covering 718 base pairs upstream from the gabDT 
coding region) and pHT5313 (covering the entire intergenic region upstream the gabT2 coding 
region) were transformed into wild type PAO1 to see how these candidate genes respond to 
exogenous GABA and AMV. While these loci were highly induced (6 folds) by exogenous 
GABA, expression patterns with exogenous AMV showed no response of the gabDT promoter, 
and only two-fold induction of the gabT2 promoter was detected in tested conditions (Figures 2.6 
and 2.7). 
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Table 2.4. Growth phenotypes of mutants with compromised GABA/AMV utilization. 
 
Strain Genotype 
Nutrients* 
Cad AMV Put GABA Glc 
PAO1 wild type ++ ++ +++ +++ +++ 
PAO5701 gabD + + + + +++ 
PAO5703 gabT + + +++ +++ +++ 
PAO5708 gabT2 ++ ++ +++ +++ +++ 
PAO5704 gabT/T2 - - +++ + +++ 
H103 wild type ++ ++ +++ +++ +++ 
PAO5723 agtS ++ - +++ ++ +++ 
PAO5724 agtA + - +++ + +++ 
* Cells were grown on MMP media agar plates with the indicated 
supplements as the sole source of carbon: Cad, cadaverine; AMV, -
aminovalerate; Put, putrescine; GABA, -aminobutyrate; Glc, glucose. 
Ammonia was added as the sole source of nitrogen. Growth was recorded in 
3 days at 37C. +++, growth after 1 day; ++, growth after 2 days; +, growth 
after 3 days; -, no detectable growth after 3 days. The gab mutants were 
derived from PAO1, and the agt mutants were derived from H103. 
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Figure 2.6. Expression profile of the gabDT promoter  
 
Specific activities of -galactosidase expressed from pMH105 for the gabD promoter 
covering 740 base pairs upstream from the coding region were measured from the host 
strains wild type PAO1, gabT mutant PAO5703 and gabD mutant PAO5701. Constitutive 
activation was detected in gabD mutant suggesting succinate semialdehyde as the inducer 
molecule of the operon. The cells were grown in glutamate (Glu) minimal medium in the 
presence or absence of-aminobutyrate (GABA), -aminovalerate (AMV), or succinate 
semialdehyde (SSA). 
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Figure 2.7. Expression profile of gabT2 promoter.  
 
Specific activities of -galactosidase expressed from pHT5313 for the gabT2 promoter 
were measured from the wild type strain PAO1. The cells were grown in glutamate (Glu) 
minimal medium in the presence or absence of-aminobutyrate (GABA), or -
aminovalerate (AMV). 
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SSA might be the activating signal of the gabD promoter. Deamination of GABA and 
AMV by GabT/T2 leads to succinate semialdehyde (SSA) and glutarate semialdehyde (GSA), 
which are further degraded by GabD into succinate and glutarate, respectively (13, 83). To 
investigate the regulatory aspects of this catabolic pathway, the gabDT expression levels in 
response to GABA or its downstream metabolite SSA were measured using the promoter-lacZ 
fusion pMH105 in the wild type PAO1 strain. As shown in Figure 2.6, although gabDT was 
inducible by both compounds, induction by GABA (5.6 folds) was stronger than SSA (3.4 folds). 
This data suggested that SSA might be the inducer molecule of the gabDT operon. To test this 
hypothesis, the gabD promoter activities were measured in the gabD (PAO5701) and gabT 
(PAO5703) mutant strains using pMH105. Curiously, gabDT expression became constitutive in 
gabD but not in gabT (Figure 2.6).  Since GabD is responsible for the degradation of SSA and 
GSA, the high expression levels detected in the gabD mutant could be caused by internal 
accumulation of either of these aldehyde compounds. However, since AMV has only marginal 
effects on the gabD promoter, its downstream metabolite GSA may not play as an activating 
signal in this pathway.  
 
Mutational analysis of the gabD promoter region. A study using serial deletions on the 5‟ 
end of the gabD promoter indicated essential elements for full activation reside within -290 base 
pairs upstream from the transcriptional starting site (29). As shown in Figure 2.8A, this region 
contains putative -70 recognition sites -10 (5‟-TAGGAT-3‟) and -35 (5‟-TTGCCC-3‟) with 17 
base pairs of distance between these two boxes. The +1 position was suggested based on 
published data from P. putida (83). At the transcription starting site, a 18 base-pairs-long 
sequence with dyad symmetry (5‟-CGTTTGAGATTTCAAACG-3‟) was found highly 
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conserved among different Pseudomonas suggesting a regulatory role involved. Two gabDT 
promoter-lacZ (transcriptional) fusions, pHT0265-1 and pHT0265-2, differing in this palindrome 
were constructed in order to test for differences in response to GABA and AMV. As shown in 
Figure 2.8B, gabDT exhibit high background expression levels when this palindrome was 
removed from the promoter region. This suggests existence of a repressor protein for gabDT 
induction.  
 
Effects of PauR on the gabD promoter. Direct interaction between GabD and its own 
promoter may serve as an alternative explanation of the high expression levels of pMH105 in the 
gabD mutant strain PAO5701. I tested for in vitro binding of purified His-GabD to the full 
length promoter region amplified from pMH105. No apparent interaction was detected using 
electrophoretic mobility shift experiments (data not shown). Therefore, the possibility of a direct 
regulation by GabD on its own promoter was excluded. On the other hand, the general repressor 
form the -glutamylation pathway, PauR, may extend its regulation to the utilization of these 
downstream metabolites. Indeed, higher levels of gabDT and gabT2 expression were detected in 
the pauR mutant (Figure 2.7 and 2.8B). While the background levels of the gabD promoter in the 
pauR mutant were elevated to the induced level in PAO1 by GABA, the background expression 
levels of the gabT2 promoter were lower than the induced level in PAO1 by GABA. 
Additionally, removal of the palindrome at the +1 site caused further induction of the gabD 
promoter in the pauR mutant strain (Figure 2.8). These data suggested a more complex 
regulatory system for GABA and AMV utilization other than a single repressor protein in this 
organism.   
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Figure 2.8. PauR regulation on the gabD promoter.  
 
A. Schematic presentation of three PgabD::lacZ promoter fusions used in this study. 
Also shown is the sequence comparison of the gabDT promoters from indicated species 
of pseudomonads. Well-conserved palindromic sequence downstream the -10 and -35 
motifs is marked with dashed arrow. The transcriptional starting site is in larger font. PA, 
P. aeruginosa; PS, P. syringae; PF, P. fluorescens; PP, P.putida; PE, P. entomophila.  
B. Effects of the palindrome on the expression profiles of the gabD promoter. Expression 
of the gabD promoter-lacZ fusions pHT265-1 (with palindrome, solid bars) and pHT265-
2 (no palindrome, empty bars) were monitored by measurements of -galactosidase 
activity in the host strains wild type PAO1 and pauR mutant PAO5722. The cells were 
grown in glucose/ammonia (GN) minimal medium in the presence or absence of-
aminobutyrate (GABA), or -aminovalerate (AMV). 
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Figure 2.9. PauR binding on gabDT promoter.  
 
PauR binding on gabDT regulatory region was demonstrated using electrophoretic 
mobility shift assays as described in Methods. Highest PauR concentration used was 6 
nM followed by 2 fold serial dilutions. Promoter regions from pHT0265-1 and pHT0265-
2 gabD promoter-lacZ fusions differing in the palindromic sequence at the +1 site (as 
shown in Figure 2.8A) were used as probes in the left and right panels, respectively.  Free 
probes were in the last lane. 
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Binding of PauR on the gabD promoter. To further confirm the role of pauR as a repressor, 
binding of PauR to the gabDT promoter region was demonstrated by electrophoretic mobility 
shift experiments (Figure 2.9). No apparent difference in binding was detectable when the 
promoter lacking the highly conserved sequence as described above (Figure 2.8A) was used as 
probe, which indicated that this palindromic sequence is not a PauR operator site. 
Conformational change in PauR was also tested using the glutaraldehyde crosslinking 
experiment as described in previous section, and no change was detectable when GABA or 
AMV was added in the reaction (data not shown). These data support PauR as a repressor protein 
on gabD and gabT2 promoter.  
 
These data confirmed that like putrescine/cadaverine, significant overlaps were found for 
GABA/AMV catabolism. The role of PauR was expanded to a general regulatory protein of the 
pathways from putrescine/cadaverine glutamylation to GABA/AMV degradation. However, 
possibilities of additional regulatory system(s) are not excluded since interacting mechanisms on 
the palindromic sequence of the gabD promoter still await identification. 
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Table 2.5. Expression profiling of the agt locus by DNA microarray 
 
    Signal Value
b
   
PA ID
a
 Gene 
Name 
 Glu Glu Glu Glu Glu Glu  Descriptions 
    Glu Arg Put GABA Lys Cad AMV   
PA0600 agtS 169 78 (0) 157 (1) 101 (1) 156 (1) 57 (0) 103 (1) two-component sensor  
PA0601 agtR 266 225 (1) 326 (1) 220 (1) 262 (1) 305 (1) 262 (1) two-component response regulator 
PA0602 
 
158 174 (1) 100 (1) 90 (1) 268 (2) 300 (2) 255 (2) putative periplasmic binding protein 
PA0603 agtA 432 497 (1) 1007 (2) 8165 1904 (4) 4269 (10) 7581 (18) 
ATP-binding component of ABC trans-
porter 
PA0604 agtB 341 481 (1) 514 (2) 4520 1102 (3) 1998 (6) 3127 (9) binding protein of ABC transporter  
PA0605 agtC 201 21 (0) 340 (2) 4767 693 (3) 2118 (11) 2259 (11) permease of ABC transporter 
PA0606 agtD 131 230 (2) 224 (2) 3136 448 (3) 927 (7) 1341 (10) permease of ABC transporter  
                    
 
a
 The PA ID numbers were taken from the PAO1 genome annotation project (www.pseudomonas.com).  
b
 GeneChip raw data are mean values from two independent sets of cultures. Cells were grown in minimal medium P supplemented with 20 mM of the following 
supplements as indicated: Glu, glutamate; Arg, L-arginine; Put, putrescine; GABA, -aminobutyrate; Lys, L-lysine; Cad, cadaverine; AMV, -aminovalerate. 
Fold changes are in parenthesis. 
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Different responses to endogenous and exogenous GABA and AMV.  Based on DNA 
microarray analysis shown in Table 2.5, PA0603-PA0605 were picked up among the entire 
transcriptome as the only locus inducible specifically by exogenous GABA (15~24 folds) but not 
by endogenous GABA produced from putrescine degradation (13). Following the logic that 
genes for GABA utilization may have relaxed specificity with AMV, I tested the importance of 
this transport system for both GABA and AMV utilization. As revealed from genetics studies, 
growth on GABA and AMV were severely affected in PA0603 (ATPase) mutant strain PAO5724 
(Table 2.4). While this transport system seemed essential for AMV uptake, growth on GABA 
was reduced but not completely depleted in PAO5724. This implies alternative uptake system(s) 
for GABA in this organism. Based on this information, PA0603~PA0605 were designated as 
AMV/GABA transport genes agtABCD. The gene organization with predicted functions was 
shown in Figure 2.10A. 
 
Upstream of the agtABCD operon, the PA0602 gene encodes another putative periplasmic 
solute-binding protein exhibiting 79% sequence similarity to AgtB. Because PA0602 is not 
present in other Pseudomonas, and it was not inducible by GABA based on the DNA microarray 
analysis, it was excluded from the agtABCD operon. 
 
Expression of the agtABCD operon responds exclusively to exogenous GABA/AMV. To 
verify my DNA microarray data, I used PAO1 harboring pHT0603 (agtA::lacZ) to test for 
responses of the Agt transport system to exogenous GABA/AMV. As shown in Figure 2.10B, the 
agtA promoter is distinctly induced by exogenous GABA (20 folds) and AMV (27 folds) when 
compared to the corresponding upstream precursors putrescine (2 folds) and cadaverine (3 folds).  
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Figure 2.10. The Agt transport system. 
 
A. Schematic presentation of the gene organization of the agt locus. The agtSR two-
component system and the agtABCD transport system genes for GABA and AMV uptake 
are highly conserved among Pseudomonas. PA0602 located between these two operons is 
unique to P. aeruginosa.  Insertion points of lux mutants analyzed in this study were 
marked with a star: lux gene was inserted with reverted orientation at the nucleotides 1091 
of the agtS coding region and with transcriptional orientation at the nucleotide 288 of the 
agtA coding region. B. Agt transport system responses exclusively to exogenous 
GABA and AMV. Specific activities of -galactosidase expressed from pHT0603 for the 
agtA promoter were measured from the host strains wild type PAO1 and gabT1/T2 double 
mutant (PAO5704) defected in GABA/AMV degradation. The cells were grown in 
glutamate (Glu) minimal medium in the presence or absence of putrescine (Put), 
cadaverine (Cad), GABA or AMV. C and D. AgtABCD transport system is regulated 
by AgtSR two component system. Specific activities of -galactosidase expressed from 
pHT0603 for the agtA promoter were measured from the host strains agtS mutant 
(PAO5723), agtA mutant (PAO5724), and the parental H103. Binding of AgtR on the 
agtA promoter was demonstrated using electrophoretic mobility shift assays as described 
in Methods. AgtR concentrations used started at 863 nM followed by 2-fold dilutions.  
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Furthermore, I used the gabT1/T2 double mutant PAO5704 defective in the transaminases 
essential for the first step of GABA/AMV catabolism to accumulate endogenous GABA and 
AMV from putrescine and cadaverine degradation. This data showed no evidence of agtA 
induction in PAO5704 by endogenous GABA/AMV, confirming exclusive response of this 
transport system to exogenous GABA/AMV (Figure 2.10B).  
 
The Agt transport system is under positive regulation of the AgtSR two-component 
system. A two-component system PA0600-PA0601 located just upstream the AgtABCD transport 
system was found as a candidate regulatory system for GABA/AMV uptake. As revealed from 
genetics studies, growth on AMV was completely depleted in PA0600 (sensor) mutant strain 
PAO5723 (Table 2.4), but growth of this mutant on GABA was leaky because of alternative 
uptake system(s) for GABA (Table 2.4). Therefore, I designated PA0600~PA0601 as agtSR two-
component system.  
 
AgtSR regulation on the agtABCD operon was further studied by measuring the agtA 
promoter activity in the agtS mutant strain PAO5723 and its parental strain H103 harboring 
pHT0603. As shown in Figure 2.10C, disruption of the sensor AgtS seemed detrimental for the 
expression of the downstream ABC transport system in PAO5723. On the other hand, in an 
electrophoretic mobility shift assay, agtA promoter (corresponding to pHT0603) interacted with 
purified His-AgtR, and the formation of protein-DNA complexes was seen (Figure 2.10D). 
 
As shown in previous sections, growth on GABA and AMV is compromised in PAO5724 
with a defected ATPase, AgtA (Table 2.4). Curiously, when measuring the expression levels of 
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pHT0603 in PAO5724, constitutive promoter activation of the agtABCD transport system was 
found in the agtA mutant strain (Figure 2.10C). This unusual pattern of promoter activities 
independent of the presence of exogenous GABA/AMV suggests that the on/off switch of the 
AgtRS system might be coupled with the AgtABCD transport system on the membrane. 
 
Effect of Agt transport system on GabDT expression. I further studied the role of Agt 
transport system in GABA/AMV utilization by measuring changes in catabolic enzymes 
expression levels in defected uptake strain. The gabDT promoter-lacZ fusion pHT0265-1 was 
transformed into PAO5723 agtS mutant to test for induction by exogenous and endogenous 
GABA and AMV. As shown in Figure 2.11, induction by exogenous GABA and AMV were 
significantly reduced with defected transport system. In PAO5723 agtS mutant strain, induction 
by GABA showed 3 folds reduction and only basal expression level was detected for AMV.  This 
data strengthened the contribution of the Agt transport system in GABA and AMV utilization. 
 
Endogenous GABA and AMV were produced as secondary metabolites from putrescine and 
cadaverine degradation, respectively. In the same set of experiment, induction levels by 
endogenous GABA and AMV sustained in agtS mutant strain suggesting GABA/AMV should 
enter the cell to trigger gabDT expression (Figure 2.11). On the other hand, since there may be 
more than one regulatory systems (other than PauR) involved in GABA/AMV catabolism, AgtR 
was subjected to gel electrophoretic mobility shift experiments as candidate positive regulator on 
gabDT. However, no AgtR binding was detectable on gabDT promoter region (Figure 2.12). 
Therefore I concluded that AgtSR senses and responds to exogenous GABA/AMV for uptake by  
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Figure 2.11. GabDT expression in Agt transport system deficient strain. 
 
Specific activities of -galactosidase expressed from pHT0265-1 for the gabD promoter 
were measured from the host strains wild type H103 and agtS mutant (PAO5723) devoid 
of the sensor component of the agt two-component system. The cells were grown in 
glucose/ammonia (GN) minimal medium in the presence or absence of putrescine (Put), 
cadaverine (Cad), GABA or AMV. 
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Figure 2.12. AgtR binding on gabD promoters was not detected 
 
Interactions of purified His-AgtR with gabD promoter regions were tested using the 
electrophoretic mobility shift assays. Two DNA probes covering the gabD regulatory 
regions with and without the palindromic sequence (corresponding to pHT0265-1 and 
pHT0265-2, respectively) were used in the experiments in the presence of a non-specific 
DNA fragment as negative control. Nucleoprotein complex was not detected. 
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the AgtABCD transport system, but may not be involved in the regulation on gabDT operon for 
GABA/AMV catabolism. 
 
In this report I performed a detailed study of putrescine and cadaverine catabolism via the -
glutamylation pathway in P. aeruginosa. Different combinations of PauA(s) were shown 
essential for putrescine and cadaverine glutamylation revealing functional redundancy of these 
enzymes and the importance of the -glutamylation pathway in this organism. PauR was 
identified as a general repressor of this pathway controlling putrescine/cadaverine glutamylation 
and GABA/AMV degradation. While putrescine and cadaverine seemed to be the inducer 
molecules of PauA activity, GABA degradation was shown under an unusual regulatory circuit 
in which an intermediate compound, SSA, served as the activating signal molecule. Additionally, 
different from putrescine, cadaverine utilization was repressed by the presence of glucose and 
glutamate as reflected from the expression profiles of the catabolic genes in response to 
cadaverine. This also implied additional level of repression on lysine utilization since 
accumulation of polyamines has been reported to inhibit lysine decarboxylase enzyme activity 
(37, 101).  
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CHAPTER THREE 
 
 
CATABOLITE REPRESSION BY CBRA-CBRB TWO-COMPONENT SYSTEM IN 
PSEUDOMONAS AERUGINOSA PAO1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This work was partially published by Laetitia Abdou, Han-Ting Chou, Dieter Haas and Chung-
Dar Lu in “Promoter Recognition and Activation by the Global Response Regulator CbrB in 
Pseudomonas aeruginosa”. J. Bacteriol. 2011 Jun; 193(11):2784-92. 
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3.1   INTRODUCTION 
 
The CbrA-CbrB two-component system was first identified to be involved in the global 
metabolic regulation of carbon and nitrogen utilization in P. aeruginosa (54, 74). While the 
inducer signals for the membrane bound CbrA sensor are unknown, CbrB is a -54 RNA 
polymerase dependent transcriptional activator of the NtrC family of response regulators (74). 
The CbrB/CrcZ/Crc pathway to control CCR through Crc was proposed by the laboratory of Dr. 
Haas in 2009 (94). The translational regulator Crc binds on mRNAs of uptake and catabolic 
genes with unpaired A-rich sequences, also termed CA motives (consensus AA
c
/uAA
c
/uAA), near 
their ribosome binding sites (66, 67, 94). CCR by Crc has been extensively studied in P. putida 
and P. aeruginosa (for review, please refer to Rojo 2010) (86). In the CbrAB/CrcZ/Crc model, 
CbrAB regulates positively the expression of the 407 nucleotide-long small-RNA CrcZ which 
contains five CA motives with high affinity for Crc to compete with mRNAs in binding (94). 
Remarkably, using succinate, glucose and mannitol as different carbon sources, CbrA/CbrB 
gradually releases catabolite repression by adjusting CrcZ expression level to antagonize Crc to 
different extends for each nutrient (94). 
 
Other than the CbrAB/CrcZ/Crc pathway, the two-component system CbrAB has other 
important targets where Crc is not involved.  Direct regulation of CbrAB has been reported for 
the lipA (lipase) gene in P. alcaligenes (41), and the hutU (histidine utilization) operon in P. 
aeruginosa and P. fluorescens (54). CbrAB system may play important role in arginine 
utilization. Promoter scan (PromScan @ Queen‟s) on aotJ-argR (arginine/lysine utilization) 
regulatory region found conserved -24/-12 boxes ATGGCTTGN4TTGCT that are typical of 
-54
 
 78 
dependent promoters (consensus TGGCACGN4TTGC
T
/A scored with 85 out of 100). This 
sequence motif is located at 273 nucleotides upstream from the start codon of the aotJ-argR 
operon. Direct binding of CbrB to the aot and hutU promoters was also proven by 
electrophoretic mobility shift experiments (Wei Li; personal communication). These evidences 
suggest direct regulation of CbrAB on the aot operon independently from Crc.  
 
As mentioned in General Introduction, CbrAB and NtrBC exhibit similar protein 
sequences and structures and were suggested to be functionally overlap. Suppressor mutants 
from a cbrAB deficient strain PAO5100 grown on arginine can be grouped into two types: 
mutants with constitutive Ntr system activation (represented by Arg18 with single mutation 
Asp227Ala on NtrB) and mutants with unknown mechanism to overcome the severe metabolic 
imbalance (represented by Arg34) (54). Ntr activation restores the ability to use histidine in 
Arg18, but still handicapped in the utilization of TCA cycle intermediates and most carbon-only 
sources. In contrast, Arg34 shows almost identical growth phenotype to the wild-type strain 
PAO1, except in histidine, ornithine and hydroxyl-L-proline utilization (54). Interestingly, the 
ratio of Arg34 (arginine positive, histidine negative, glucose positive) to Arg18 (arginine 
positive, histidine positive, glucose negative) is high (85:5). It is possible that the ability of 
Arg34 to grow on a wide range of compounds is due to mutations on CrcZ to release CCR by 
Crc. 
 
In this study, direct interaction of CbrB on the crcZ promoter was shown by 
electrophoretic mobility shift experiments. Two putative upstream activating sequences (UASs) 
on crcZ regulatory region were proven to contribute in CbrB recognition. Participation of 
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CbrAB, Crc and NtrBC systems were analyzed for arginine, lysine, putrescine and cadaverine 
catabolism using genetics approach.  
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Table 3.1. Strains and plasmids 
 
Strain or plasmid Genotype or description 
a
  Source 
E. coli strains   
DH5 F
-Φ80dlac ∆M15 ∆(lacZYA-argF)U169 deoR recA1 endA1 
hsdR17 (rK
-
 mK
-
) supE44 λ- thi-1gyrA96 relA 
Bethesda 
Research 
Laboratories 
TOP10 F- mcrA (mrr-hsdRMS-mcrBC) 80lacZM15 
DlacX74 recA1 araD139 (ara-leu)7697 galU galK rpsL 
(Sm
r
) endA1 nupG 
Invitrogen 
P. aeruginosa strains   
PAO1 Wild type (27) 
PAO5100  cbrAB::Gmr  (59) 
PAO4727  cbrAB::Gmr;  crc  
PAO5126  cbrAB::Gmr; ntrBC::Tcr   (54) 
   
Plasmids   
pCBRB Amp
r 
pUCP18 derivative carrying the wild type  
cbrB fragment of PAO1 
This study 
pCBRB* Amp
r 
pUCP18 derivative carrying K98Q cbrB This study 
pME9834 crcZ-lacZ with 116-bp promoter region; Tc
r
  (1) 
pME9842 crcZ-lacZ with 138-bp promoter region; Tc
r
  (1) 
pME9843 crcZ-lacZ with 161-bp promoter region and mutated motif 2 
(Mut2) in the UAS; Tc
r
   
(1) 
pSU300 pBAD/HisB carrying truncated cbrB  This study 
a
 Gm
r
, gentamicin resistance; Tc
r
, tetracycline resistance; Amp
r
, ampicillin resistance.
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  3.2   MATERIALS AND METHODS 
 
Bacterial strains, plasmids, media, and growth conditions. Bacterial strains and plasmids 
used in this study are listed in Table 3.1. P. aeruginosa strains were grown in Luria-Bertani (LB) 
and 2X tryptone-yeast extract media (2YT) supplemented with or without antibiotics at 
conventional concentrations (104). Minimal medium P (27) containing the indicated carbon 
sources at 20 mM and nitrogen sources at 5 mM was used for the growth of P. aeruginosa. 
 
Plasmid construction. Full length CbrB was amplified by PCR from the genomic DNA of P. 
aeruginosa PAO1 and subcloned into pUCP18 EcoRI and HindIII sites to construct pCBRB 
using the following primers: CbrB_F, 5‟-GCT GAA TTC GGC ACA TAT TCT GAT CGT CGA 
AGA CG-3‟and CbrB_R, 5‟- GCT AAG CTT CTG TTA CGC GGT ACG TCC GCG GTA AC-3‟. 
The K98Q mutation on CbrB was introduced into pCBRB to construct pCBRB* using the 
following primers: CbrB*_F, 5‟-GTG GAC TAC ATC GCC CAG CCT TTC GAC CAC G-3‟and 
CbrB*_R, 5‟-CGT GGT CGA AAG GCT GGG CGA TGT AGT CCA C-3‟.  
 
Purification of His-CbrB. His-tagged truncated „CbrB (His-CbrB) protein was expressed 
from pSU300 in E. coli TOP10 (Invitrogen). The resulting recombinant „CbrB protein lacks the 
13 N-terminal amino acid residues of the native CbrB protein and carries an N-terminal His6 tag. 
After induction by 0.2 % (w/v) arabinose for 3 h, cells were collected by centrifugation and 
ruptured by passing through a French pressure cell at 8,500 lb/in
2
. Cell debris was removed by 
centrifugation at 25,000×g for 30 min, and the resulting cell-free crude extract was loaded onto a 
HisTrap HP column (GE Healthcare) in an AKTA FPLC system, following a purification 
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protocol suggested by the manufacturer. The recombinant His-CbrB protein was eluted by 175 
mM imidazole. The purity of His-CbrB in the collected fractions was verified by SDS-PAGE. 
Protein concentration was determined
 
by the Bradford method with bovine serum albumin as 
standard. 
 
Electrophoretic mobility shift assays. DNA fragments covering wild-type and mutated 
regulatory regions were PCR-amplified from the genomic DNA and plasmids as described in 
Abdou et al (2011). DNA probes were prepared by labeling them with [γ-32P]ATP and T4 
polynucleotide kinase (34). Radioactively labeled DNA probes were allowed to interact with 
different concentrations of purified His-CbrB in a 20-μl reaction mixture containing 50 mM Tris-
HCl (pH 7.5), 50 mM KCl, 1 mM EDTA, 5 % (v/v) glycerol, 150 μg/ml acetylated bovine serum 
albumin, and 40 ng cold pUC18 vector as non-specific DNA. The reaction mixtures were 
incubated at room temperature for 30 min before being applied to a 4 % polyacrylamide gel (bis-
acrylamide ratio 1:60) in 0.5 TBE buffer pH 7.5. The gel was dried, auto-radiographed by 
exposure to a phosphorimager plate, scanned using FLA-7000 version 1.1, and analyzed by 
Multi Gauge version 3.0 (FUJIFILM). 
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Figure 3.1. Domains of the CbrB protein.  
 
Domain map with conserved sequences in the CbrB and NtrC proteins of P. aeruginosa 
PAO1, based on the domain map of Salmonella enterica NtrC (22). CbrB is predicted to 
contain an N-terminal regulatory domain, a central 54 activation domain and a C-
terminal DNA-binding domain with a helix-turn-helix motif (HTH). The conserved 
phosphorylation site in the regulatory domain is presumed to enable activation of CbrB 
by the sensor kinase CbrA (5, 30). Grey boxes below show that the 13 N-terminal amino 
acid residues of the native CbrB protein are replaced by 35 different amino acids 
including a his6 tag in the truncated CbrB protein. 
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3.3   RESULTS AND DISCUSSION 
 
Direct evidence of CbrB regulation on crcZ promoter. The regulator CbrB shows 
similar protein structure to the well known bacterial enhancer binding protein NtrC with 43% 
identity and 62% similarity in amino acid sequences. As shown in Figure 3.1, this family of 
regulatory protein exhibits an N-terminal regulatory/receiver domain with a conserved aspartate 
residue (D52 of CbrB) to be the cognate sensor phosphorylated by CbrA, a central domain to 
interact with -54 RNA polymerase, and a C-terminal helix-turn-helix DNA binding domain. It 
had been reported inhibitory effect of the regulatory domain on the binding activity of some 
members of the NtrC family and truncation of the N terminus can enhance this activity (25, 77).  
 
Here I study the direct regulation of CbrB on CrcZ promoter as suggested in 
CbrAB/CrcZ/Crc model. Full length and truncated His-tagged CbrB protein were over-expressed 
and purified from E. coli and subjected to electrophoretic mobility shift experiments as described 
in methods. In general, optimal conditions for in vitro binding activity of CbrB was very hard to 
find and only the truncated CbrB lacking the 13 N-terminal amino acid residues was able to 
show binding on crcZ promoter in tested conditions (Figure 3.2, full length CbrB was not shown). 
 
The crcZ promoter contains conserved -24/-12 boxes typical of -54 promoters (Figure 
3.2). The region -151 to -125 from the transcriptional starting site of crcZ contains palindromic 
sequences (TGTTAC and GTAACA separated by 14 nucleotides) which may function as UAS 
elements to be recognized by CbrB. Therefore, I PCR amplified these regions containing wild 
type as well as mutated sequences of these elements using constructs provided by Dr Haas as 
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template (1), and subjected to electrophoretic mobility shift experiments. As shown in Figure 3.2, 
deletion of both elements of the palindromic UAS (M1,2) abolished CbrB binding, whereas 
either deletion of the upstream element (M1) or mutation of the downstream element (Mut2) 
resulted in diminished CbrB binding. These data indicated that a single element in the UAS was 
sufficient for CbrB binding. However, both elements might be needed for strong binding and full 
activation of the crcZ promoter.  
 
CbrB interaction on lipA promoter. In P. alcaligenes, the expression of the lipA gene 
coding for secreted lipase is positively controlled by RpoN and by the LipQ/LipR two-
component system, the counterpart of CbrA/CbrB in P. aeruginosa (41). A UAS has been 
proposed as a LipR (CbrB) binding site At -130 to -112 of the lipA promoter (16). Here I 
investigated the molecular details of the lipA promoter and its putative UAS in P. aeruginosa. In 
an electrophoretic mobility shift assay, the purified His-CbrB protein interacted with the wild-
type lipA promoter region at the highest protein concentration used, but caused no band shift of a 
promoter fragment lacking the UAS (Figure 3.3). The relatively low affinity of His-CbrB for the 
UAS in the lipA promoter reflects a suboptimal recognition sequence, by comparison with the 
UAS in the crcZ promoter. 
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A. 
 
 
 
 
 
 
 
 
 
 
B. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2. His-CbrB binds to the UAS of the crcZ promoter in vitro  
 
A. Sequence of the crcZ promoter region and recognition sites for CbrB. In the nucleotide 
sequence of the crcZ promoter region, the 45-bp UAS region is highlighted in grey. The 
cbrB stop codon, the motif 1 and motif 2 of the UAS, and the -24 and -12 elements of the 
54 promoter are all shown in boxes. Inverted arrows show a palindromic sequence in the 
UAS region; arrows with solid lines below boldface nucleotides indicate the extent of the 
CbrB consensus binding site. Dashed inverted arrows show a putative -independent 
terminator of the cbrB transcript. An arrow at +1 shows the start of crcZ transcription. B. 
Interactions of radioactively labeled wild-type and mutated crcZ regulatory regions. 
Different concentrations of purified His-CbrB were analyzed by electrophoretic mobility 
shift assays. DNA probes covering crcZ promoter from the UAS region (highlighted in A) 
to +1 transcription starting site were used for probes preparation as described in Methods. 
WT, wild-type probe, Mut2, mutated motif 2, ΔM1, deletion of motif 1, and ΔM1,2, 
deletion of motifs 1 and 2, corresponding to pME9834. Concentrations of His-CbrB in 
lanes 1 to 5 were: 760 nM, 380 nM, 76 nM, 15 nM and 0 nM, respectively. 
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A. 
 
 
 
 
 
 
 
 
 
B. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3. Sequence of the lipA promoter region, recognition site for CbrB and ca-
tabolite repression of the lipA promoter. 
 
A. In the nucleotide sequence of the lipA promoter, the UAS region is highlighted in 
grey. The ligT stop codon, the -24 and -12 elements of the 54 promoter, and the lipA start 
codon are boxed. Inverted arrows below boldface nucleotides show the palindromic 
sequence in the UAS region. An arrow at +1 shows the start of lipA transcription. B. 
Interactions of the radioactively labeled wild-type lipA promoter corresponding to 
pME9831 (PlipA; 0.1 nM) with different concentrations of His-CbrB were tested in vitro 
by electrophoretic mobility shift experiments as described in Methods. Concentrations of 
His-CbrB in lanes 1 to 5 were: 1520 nM, 760 nM, 380 nM, 190 nM and 0 nM, 
respectively. The crcZ promoter region devoid of motifs 1 and 2 (ΔM1,2) served as 
negative controls in lane 6 (no His-CbrB) and lane 7 (1520 nM of His-CbrB). 
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CbrAB/CrcZ/Crc may play partial role in regulation of basic amino acids and 
polyamines utilization. When CbrAB is deficient, no CrcZ will be expressed to antagonize Crc 
repression resulting in permanent inactivation of target pathways. Histidine and arginine 
utilization has been thought to be regulated by CbrAB two-component system independent from 
CCR by Crc. In this study, as a continuation from previous chapters, I tested for growth of 
mutant strains cbrAB (PAO5100), cbrAB/ crc (PAO4727), and cbrAB/ntrBC (PAO5126), on 
positively charged biomolecules such as L-histidine, L-arginine, L-lysine, agmatine, putrescine 
and cadaverine. Since CbrA-CbrB and Crc are for carbon regulation, and NtrB-NtrC for nitrogen, 
no growth difference between cbrAB and cbrAB/ntrBC mutant strains was expected when 
nutrients were provided as sole source of carbon and nitrogen. In contrast, comparison between 
cbrAB and cbrAB/ crc mutants was quite interesting; it can differentiate catabolism that is 
controlled by cbrAB alone or by the coordinated cbrAB/CrcZ/Crc system. As shown in Table 3.2, 
different growth patterns were obtained for L-histidine from L-arginine and polyamines. While 
histidine utilization seemed independent from Crc repression, growth on L-arginine, agmatine 
and polyamines were partially restored when crc was further mutated in cbrAB genetic 
background to release CCR (PAO4727). This data suggested involvement of the cbrAB/CrcZ/Crc 
system in the utilization of arginine, lysine, agmatine, putrescine and cadaverine. In contrast, 
growth on GABA and AMV were just slightly affected in CbrAB. 
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Table 3.2. Growth phenotypes of CbrAB, Crc and NtrBC mutants 
 
 
Nutrients* 
Genotype  
wild type  cbrAB  
cbrAB 
crc 
cbrAB 
ntrBC 
Histidine ++++ - - - 
Arginine ++++ - ++ - 
Agmatine ++++ - +++ - 
Putrescine ++++ - +++ - 
GABA ++++ +++ ++++ +++ 
Lysine + - + - 
Cadaverine ++ - + - 
AMV +++ ++ +++ + 
 * Cells (10
4
) were grown on MMP media plates 
supplemented with 10 mM of different energy sources. 
Growth was recorded during 3 days of incubation period. 
++++: prominent growth after 1 day; +++: good growth after 
1 day; ++: good growth after 2 days; +: growth after 3 days; -: 
no detectable growth after 3 days. 
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Figure 3.4. Proposed CbrB consensus in P. aeruginosa  
 
The CbrB binding sites in the crcZ and lipA promoters of P. aeruginosa were determined 
in this work. Preliminary data on the aotJ promoter of P. aeruginosa reveal similar 
conserved palindromic sequences. Their alignment suggests a consensus CbrB binding 
site with variable spacer lengths of 3, 12 or 28 nucleotides. 
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Possible cross-talk between NtrBC and CbrAB was not found. Combined regulation 
of CbrAB with NtrBC has been reported for arginine and histidine utilization in pseudomonas 
(54, 107). Based on sequence and structure similarities, possible cross-talk may occur between 
the sensors and regulators of these two-component systems. Based on studies of NtrC regulatory 
phosphorylation in E. coli, replacing the lysine residue 104 by glutamine (K104Q) prevents 
dephosphorylation of the aspartate residue on NtrC receiver domain (79). Based on amino acid 
sequence similarity, CbrB K98Q was predicted as the corresponding mutation site of NtrC 
K104Q. I introduced pCBRB and pCBRB* carrying wild type CbrB and mutated CbrB K98Q, 
respectively, into wild type PAO1 and cbrAB mutant PAO5100. However, no difference in 
growth was found on minimal media P agar plates where nutrients tested in Table 3.2 were 
provided as the sole source of carbon and nitrogen (data not shown). These results implied CbrA 
is necessary for CbrB activation and there may be no cross-talk between NtrB sensor and CbrB 
regulator. 
 
Comparison of CbrB recognition sites in P. aeruginosa. Direct binding of CbrAB were 
shown for the crcZ and lipA genes in this study. Based on stronger binding of CbrB and the 
palindromic symmetry of these elements on the crcZ promoter, CbrB consensus was proposed 
based on the UAS of crcZ promoter (Figure 3.4). This allowed me to predict putative UASs on 
aotJ promoter. Putative CbrB recognition sites were found at 455 and 419 nucleotides upstream 
from the start codon of the aotJ promoter (gcGTTtCg N28cGTAACAa). These two elements 
found on the aotJ promoter are almost identical to those in the lipA promoter but with a longer 
spacer sequence (Figure 3.4). More studies are required to verify CbrB regulation on 
arginine/lysine utilization through these elements.  
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The crc and crcZ promoters were intact in Arg34. As mentioned in Introduction, 
suppressor mutants obtained from cbrAB mutant on arginine plates can be classified into two 
types based on their ability to growth on histidine and glucose. The Arg34 strain represents the 
phenotype of the majority of these suppressor mutants with positive growth on sugars and TCA 
intermediates as carbon sources but cannot grow on histidine (54). Since the CbrAB/CrcZ/Crc 
pathway affects a wide range of metabolic pathways, mutations in genes of this pathway may 
release from the permanent repression of Crc. To verify this hypothesis, I PCR amplified the 
regions of the crc gene and the crcZ gene (covering coding and upstream intergenic regions) for 
DNA sequencing analysis. However, the results revealed no difference in these regions between 
Arg34 and the wild type PAO1 strains (data not shown).  
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GENERAL DISCUSSION 
 
Using DNA microarray to understand microbial metabolic pathways. DNA 
microarray experiments were conducted to see genome wide response to exogenous L-lysine, L-
arginine and polyamines in P. aeruginosa. For L-lysine utilization, this approach did not give 
direct indications since important genes for L-lysine utilization identified so far in this study 
were under L-arginine/ArgR control (Table 1.2). This also led to misjudge ldcA (PA1818) as a 
candidate of L-arginine decarboxylase gene during the initial studies of our laboratory (29).  
Fortunately, growth phenotype studies were able to explain the microarray data with the peculiar 
connection between L-lysine and L-arginine catabolism as reported in this study (Chapter I).  
 
 With a relatively large genome of 5,570 open reading frames, traditional genetic 
approaches such as random mutagenesis may be difficult for the identification of candidate genes, 
especially when there were several homologous genes with relaxed specificity such as the case of 
seven -glutamyl-polyamine synthetases for polyamine catabolism (Chapter II, Table 2.2). 
Different from putrescine, cadaverine is under catabolite repression from other energy sources 
such as glutamate. Since all cells were grown in glutamate minimal media for this set of DNA 
microarray data, response to cadaverine was severely inhibited. Therefore, candidate genes for 
the -glutamylation pathway (pauA, pauB, pauC and pauD) were selected based on putrescine 
DNA microarray. Roles of these genes in cadaverine utilization were also confirmed by 
promoter-lacZ fusions and genetics studies. Additionally, it was unusual that almost all genes 
inducible by putrescine or agmatine were also inducible by GABA (Table 2.2). It is intriguing 
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that genes responsible for the -glutamylation pathway were inducible by the downstream 
metabolite GABA where feedback inhibition is commonly found.  
 
Besides the proposed oxidative deamination by PauB from E. coli, an alternative 
transamination reaction was suggested for the second step of the -glutamylation pathway 
regardless of the oxygen level (Figure 2.1). The transaminase SpuC was proposed for this 
alternative route with L-alanine production from pyruvate. Interestingly, an induced dadAX 
operon was found to ensure the recycling of pyruvate for the transamination reaction (Table 2.2) 
(13, 28). This data implies contribution of this alternative route in polyamine utilization. 
 
Clinical decarboxylase assay could be modified for P. aeruginosa detection. 
Pseudomonas aeruginosa causes constant life-threatening infections to hospitalized 
immunocompromised patients due to its versatile metabolic capacity and quick antibiotic 
resistance development (17, 87). One of the most common clinical procedures for identification 
of Enterobacteriaceae and other gram-negative enteric bacilli is the biochemical differentiation 
using decarboxylase media (61). This colorimetric test is based on pH changes first by sugar 
fermentation followed by activation of arginine dihydrolase and lysine and ornithine 
decarboxylases as part of acid stress response. Because of its low cost and simplicity, this 
approach is widely used before more expensive and time-consuming experiments such as PCR or 
DNA microarray for identification. While I demonstrated that L-lysine decarboxylation is the 
main route of L-lysine catabolism in P. aeruginosa, this test is negative for this organism. It is 
generally believed that P. aeruginosa is not adequate due to its inability to ferment certain sugars 
under anaerobic conditions. This may be true for the acid stress response through arginine and 
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ornithine decarboxylation, however, the lysine decarboxylase identified in this study exhibits 
optimal conditions at physiological pH. Since the bottle neck of lysine decarboxylation is the 
inducer arginine, it may be useful adding some arginine and adequate pH sensors in the media to 
identify P. aeruginosa. This early identification may be of primordial importance to avoid 
delayed treatment for immunocompromised patients in intensive care units. 
 
Methods for lysine decarboxylase assay. In the first part of this study, I performed the 
enzyme characterization of lysine decarboxylase LdcA using radiolabeled [
14
C]-L-lysine (98).  
This radiometric method may be one of the most traditional approaches for biochemical enzyme 
characterization which is generally avoided because of the usage of isotope. Other laborious 
methods include manometric and multi-step spectrophotometric approaches (4, 78). The most 
recent advance for this enzymatic reaction uses macrocycle-fluorescent dye complexes to allow 
continuous monitoring of the product production (30). Actually, our laboratory selected this new 
method as my first test for LdcA characterization using the macrocyclic cation receptor 
cucurbit[7]uril (CB7) and Dapoxyl complex. The idea is based on the differential affinity 
between lysine and cadaverine (product of decarboxylase) to CB7. Ideally, it should be able to 
monitor the change in fluorescence when Dapoxyl is titrated out throughout cadaverine 
production. Unfortunately, even this method is successful using lysine decarboxylase from E. 
coli at pH 6.0, I found it impossible for my enzyme because the fluorescence intensity is ten-
folds weaker at the optimal pH of my enzyme (data not shown). Therefore I concluded that this 
approach is not adequate for a complete enzyme characterization. 
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The second method I tested was the spectrophotometric approach using 2,4,6-
trinitrobenzenesulfonic acid (TNBS). This multi-step assay takes the advantage of the water 
insolubility of the complex formed by cadaverine and TNBS which can be extracted by toluene 
(78). This method has been widely used for three decades and most reports on lysine 
decarboxylase consider it as a standard procedure for enzymatic reaction. Curiously, I found a 
dramatic drop in LdcA enzyme activity once it reaches the maximum velocity around 5 mM 
lysine concentration suggesting strong substrate inhibition kinetics (Appendix A). Similar pattern 
was published in the original paper where this method was developed by Phan at al in 1981. 
However, when I tried to analyze the enzyme kinetics with this set of data using GraghPad Prism 
5 software, the inhibitory effect is so strong that the values cannot fit into the substrate inhibition 
equation using non-linear regression curve fit (Figure A.2). This intrigued me, so I used the 
radiometric approach to double confirm my doubt. Surprisingly, the kinetics obtained from this 
old-fashioned method was totally different from previous approaches exhibiting cooperative 
substrate activation pattern (Figure 1.1). Therefore, I decided to perform the complete enzyme 
characterization using this last method because of the simplicity and stability in chemistry which 
may cause minimal secondary effects in the reaction. 
 
Instability of the pauA mutants. The presence of seven glutamyl-polyamine synthetases 
in P. aeruginosa cause technical difficulties to conduct genetic analysis. The serial cloning 
conducted by our laboratory for different combination of pauA(s) knockouts with markerless 
gene replacement using the Flp-FRT recombination system was an extensive work (32, 105). 
This was not only because of the large number of genes and possible combinations; one of the 
problems that I encountered was the instability between FRT cassettes with proximal locations. 
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For the case of mutants containing pauA1 and pauA2 double mutations, the chromosome 
fragment between them (which includes spuA gene) may be unexpectedly inverted by the FRT 
cassettes. To avoid this, I had to leave the gentamicin resistant cassette in either pauA1 or pauA2. 
Additionally, the physiology of the mutant strain M7 devoid of all PauA1-7 is significantly 
different from the wild type PAO1. This may be due to its inability to use polyamines. And I 
encounter difficulties to perform chemical transformation experiments with this strain. 
Therefore, the M6 mutant PAO5725 with gentamicin resistance cassette on pauA2 was used in 
Chapter II for experiments involving transformation since this mutant strain has all pauA(s) for 
diamine utilization mutated/deleted and exhibits same growth phenotype than M7 on putrescine 
and cadaverine. 
 
Difficulties with handling purified His-CbrB protein. In the last part of this thesis, 
recognition sites for the CbrB response regulator have been identified in the upstream region of 
the crcZ and lipA promoters. This interaction allows CbrB to drive the expression of the small 
RNA CrcZ which antagonizes the CCR repression by Crc in P. aeruginosa. The purification 
procedure and in vitro binding experiments were not easy for CbrB due to the high instability of 
purified protein and sub-optimal conditions for protein-DNA interaction. Different expression 
and purification schemes were tested to yield soluble active CbrB protein of high purity. His-
CbrB can only be expressed at 37C and detergent or glycerol was required to avoid immediate 
precipitation. Furthermore, without the N-terminal truncation, in vitro interaction between DNA 
with native CbrB or full length His-CbrB was not detectable in the electrophoretic mobility shift 
assay. I also tested for different binding and gel electrophoretic conditions by changing the 
buffer, pH, temperature, salt, DTT, etc. However, the affinity calculated from the best set of data 
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still showed poor interaction of CbrB on proposed binding sequences. I also encountered 
difficulties in performing CbrB footprinting with crcZ and lipA promoters. The DNase I 
digestion worked perfectly. However, there was no footprinting even with the wild type crcZ 
probe. It turned out that the recombinant His-CbrB was very sensitive to Mg
2+
 ion which was 
necessary for the DNase I activity.  
 
Different functions of CbrAB/CrcZ/Crc regulation were proposed. Recent reports 
have extended the functions of the CbrAB/CrcZ/Crc signal transduction pathway beyond the 
control of catabolic pathways. A proteomic analysis has shown Crc repression on some porins 
biosynthesis affecting the susceptibility to certain antibiotics (56).  Decreased biofilm formation, 
motility and cytotoxicity were also noted in cbrB and crcZ mutants (106). However, opposite 
effects were observed by another group on biofilm formation when rich media was used (71). It 
has been reported in several bacterial species that CCR systems can influence the expression of 
genes related to virulence (24). It is possible that with severe defects on the regulation of 
metabolism as in the cbrAB mutants, virulence traits might be directed to facilitate access to new 
sources of nutrients.  
 
Throughout these series of studies on basic amino acids and polyamine catabolism, I am 
amazed by the large metabolic capacity and versatility of Pseudomonas aeruginosa. How this 
bacterium develop a connection to the complex arginine network for lysine utilization, the 
number of redundant enzymes in several steps of the -glutamylation pathway, and the 
sophisticated metabolic regulation by CbrA-CbrB and Crc, deserve our respects for its incredible 
metabolic flexibility and survival ability in different environments. 
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APPENDIX A 
DIFFERENT LDCA ENZYME KINETICS IN SPECTROPHOTOMETRIC PPROACH  
As mentioned in General Discussion, different methods were tested for lysine 
decarboxylase enzyme kinetics studies.  In this section, a widely used spectrophotometric 
approach was tested for initial enzyme characterization (78). However, the kinetics obtained 
using this method was significantly different from the data using radiolabeled lysine as in 
Chapter One. 
 
LdcA protein purification. The construct pHT1818 from Chapter One was used for full 
length LdcA expression and purification form E. coli TOP10 as described before (52, 103). As 
shown in Figure A1, lowering induction temperature seemed to help dramatically on the correct 
folding and hence solubility of the enzyme.  
 
 
 
 
 
 
 
 
 
 
 
            Figure A.1. LdcA solubility depends on expression temperature.  
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 LdcA enzyme assay using spectrophotometric approach. Purified LdcA from above 
section was used to test L-lysine decarboxylation in vitro. The reaction mixture contains 0 mM to 
50 mM L-lysine as the substrate and 125 M pyridoxal-5‟-phosphate as the cofactor. Enzyme 
activity was detected using a spectrophotometric method (78). Cadaverine and lysine can form 
colorimetric adducts with 1.02 X 10
-2
 M 2,4,6-trinitro-benzenesulfonic acid (TNBS). Base on the 
differential solubility of the reaction products in toluene, TNP-lysine and TNP-cadaverine, lysine 
decarboxylation rate was quantified by measuring the concentration of TNP-cadaverine extract 
from the organic phase by spectrophotometry. A standard curve was determined using 
cadaverine. Readings were obtained from toluene extracts using OD at 340nm. An average 
extinction coefficient for TNP-cadaverine was found to be 1.04 x 10
4
 M
-1
cm
-1
. Enzyme kinetics 
was analyzed using GraphPad Prism 5.0 and failed to fit into Substrate Inhibition Equation using 
Non-linear Regression Curve Fit. 
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Figure A.2. LdcA kinetics does not fit to non-linear regression curve with substrate 
inhibition equation.  LdcA was purified to homogeneity to perform enzyme characterization 
using a colorimetric method in Tris buffer pH 8.5 as described above. Enzyme kinetics was 
analyzed using GraphPad Prism 5.0. 
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APPENDIX B 
TRANSCRIPTOME ANALYSIS OF AGMATINE AND PUTRESCINE CATABOLISM 
IN PSEUDOMONAS AERUGINOSA PAO1 
 
 
 
 
 
 
 
 
 
This work was published by Han-Ting Chou, Dong-Hyeon Kwon, Mohamed Hegazy and 
Chung-Dar Lu in “Transcriptome Analysis of Agmatine and Putrescine Catabolism in 
Pseudomonas aeruginosa PAO1”. J. Bacteriol. 2008 Mar; 190(6):1966-75. 
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APPENDIX C 
LIST OF PUBLICATIONS ON SCIENTIFIC JOURNALS 
 
1) Cadaverine and Putrescine Catabolism through -Glutamylation in Pseudomonas aerugino-
sa PAO1. Chou HT, Wu J,
 
and Lu CD. Article in preparation 
 
2) Promoter Recognition and Activation by the Global Response Regulator CbrB in Pseudo-
monas aeruginosa. Abdou L, Chou HT, Haas D,
 
and Lu CD. J Bacteriol. 2011 Apr 
doi:10.1128/ JB.00164-11 
 
3) L-lysine Catabolism is Controlled by Arginine/ArgR in Pseudomonas aeruginosa PAO1. 
Chou HT, Hegazy M, Lu CD. J Bacteriol. 2010 Nov;192(22):5874-80. 
  
4) Synthesis and evaluation of new antagonists of bacterial quorum sensing in Vibrio harveyi. 
Peng H, Cheng Y, Ni N, Li M, Choudhary G, Chou HT, Lu CD, Tai PC, Wang B. 
ChemMedChem. 2009 Sep;4(9):1457-68. 
 
5) Inhibition of quorum sensing in Vibrio harveyi by boronic acids. Ni N, Choudhary G, Peng 
H, Li M, Chou HT, Lu CD, Gilbert ES, Wang B. Chem Biol Drug Des. 2009 Jul;74(1):51-6. 
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6) Structure-based discovery and experimental verification of novel AI-2 quorum sensing in-
hibitors against Vibrio harveyi. Li M, Ni N, Chou HT, Lu CD, Tai PC, Wang B. 
ChemMedChem. 2008 Aug;3(8):1242-9. 
 
7) Identification of boronic acids as antagonists of bacterial quorum sensing in Vibrio harveyi. 
Ni N, Chou HT, Wang J, Li M, Lu CD, Tai PC, Wang B. Biochem Biophys Res Commun. 
2008 May 2;369(2):590-4.  
 
8) Transcriptome analysis of agmatine and putrescine catabolism in Pseudomonas aeruginosa 
PAO1. Chou HT, Kwon DH, Hegazy M, Lu CD. J Bacteriol. 2008 Mar;190(6):1966-75.  
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